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CHAPTER I
INTRODUCTION
1.1 CENTRAL DOGMA
The survival of a cell depends on its ability to regulate its genetic program, which
is crucial for growth, proliferation and homeostasis. Understanding how these programs
operate and are regulated is the focus of a wide range of biological disciplines including
evolution, genetics, biochemistry and developmental biology. The central dogma of
molecular biology describes the process of gene expression. The first step in gene
expression is the conversion of genetic programs coded in the bases of DNA to RNA by
a process called transcription. In the next step, RNA is translated into proteins, which
perform nearly all the vital functions of a cell. The basic unit of the genetic program is a
‘gene’, which is a region of the DNA that includes the promoter, the coding region and
the terminator. Although, gene expression is regulated at multiple levels, transcription is
the first major step, and a primary target of regulatory processes. In order to have an
insight into the regulation of gene expression, therefore, it is critical to understand how
transcription is regulated.
1.2 RNA POLYMERASES
In eukaryotes, the process of transcription is performed by at least three different
RNA polymerases (RNAP) (253, 254). RNAP I and III transcribe ribosomal rRNA, tRNA,
and small nuclear RNAs (snRNA), while RNAP II is the enzyme that transcribes protein
coding genes as well as some snRNAs and non-coding RNAs (300). The overall
process of transcription can be broken down into three basic steps: initiation, elongation
and termination. Transcription often begins in response to a signal, which is transduced
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to a protein inside the cell called the ‘activator’. This triggers the activator-dependent
recruitment of the general transcriptional machinery onto the 5' end of a gene called the
‘promoter’ to form a preinitiation complex (PIC). The initiation of transcription takes
place while polymerase is still bound to the promoter as a part of the initiation complex.

Soon after initiation, polymerase is released from the initiation complex leaving behind
most of the components of initiation complex on the promoter as a ‘scaffold’ (324). This
transition from initiation to elongation is called promoter clearance, which is
accompanied by the recruitment of elongation factors. As RNA polymerase reaches the
3' end of the gene, the termination factors are recruited by the elongating polymerase.
The termination factors facilitate 3' end processing of mRNA and the release of
polymerase from the DNA template (266). A schematic of the basic steps in the
transcription cycle for a protein coding gene is shown in figure 1.
All three forms of RNA polymerases exhibit similarity in structure and function
over a wide range of taxa (174, 175). Eukaryotic RNAP II is comprised of 12 subunits
(312). These subunits have been named Rpb1 to Rpb12. Of these 12 subunits, only
Rpb4 and Rpb9 are not essential for survival of yeast cells (311, 313). Ten subunits
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form the core enzyme, while Rpb4 and Rpb7 form a heterodimer that associates with
the core to form the 12 subunit structure (39). The core enzyme can perform RNA
synthesis, but is incapable of initiating transcription from a promoter, and often displays
termination defect (256). Rpb4 and Rpb7 were found important for promoter-based
initiation in vitro, while Rpb4 has also been implicated in the recruitment of 3’ end
processing/termination factors (11, 68, 161, 256). The subunits Rpb5, Rpb6, Rpb8,
Rpb10 and Rpb12 are shared by all three RNA polymerases (291). With the exception
of Rpb1, the remaining subunits also exhibit some degree of similarity among the three
types of polymerases (116). Years of work from the Roger Kornberg and Patrick Cramer
laboratories have provided key structural analysis of RNAP II in a complex with other
transcription factors and DNA (11, 12, 38-40, 51, 69, 104, 148, 153, 154, 162, 195, 304,
305). These structural studies have provided key insight into the functional aspects of
the transcription machinery. The two largest subunits of RNAP II together form the
active site of the enzyme, and the binding sites for DNA and RNA. Rpb3, Rpb6 and
Rpb11 are important for stabilization of the structure of the complex, while the remaining
subunits are thought to provide interaction surfaces for regulatory factors (301). The
largest subunit of RNAP II, Rpb1, contains a unique carboxyl terminal domain (CTD)
consisting of an array of heptapeptide repeats that serve as a loading dock for the
transcription factors and RNA processing factors during the transcription cycle (35).
The promoter and terminator regions mark the distal ends of a gene and are
composed of specific sequence elements that bind transcription factors. Upstream
activating or repressing sequences (UASs or URSs) are located upstream of the core
promoter and bind activator and repressor proteins respectively. In yeast, the vast
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majority of UASs and URSs are located upstream of the core promoter element, usually
within a few hundred bp of the transcription start site (TSS, Fig. 2) (59, 60, 87, 91, 107,
214, 273, 319). The combinatorial input from these upstream sequences converge onto
the promoter near the TSS through the action of coactivators and the general
transcription factors (GTFs). A core promoter was first discovered in humans (Fig. 2),
which is the minimal set of sequences required to initiate transcription (271). It is a
sequence of 80 bp centered around the TSS that contains several conserved elements:
TATA-box,

initiator

element

(INR),

TFIIB

recognition

element

(BRE),

downstream positioning element (DPE) and the motif ten element (MTE). The TATAbox, INR, DPE and MTE are all sequences recognized by the general transcription
factor IID (TFIID), while the BRE is an element recognized by the general transcription
factor IIB (TFIIB) (146). In yeast, only the TATA box and INR like motifs have been
found, the others are presumably present but too degenerate to be identified positively
(116).
1.3 INITIATION
The initiation is the most well understood step of transcription owing to a large
body of in vitro studies being performed using a promoter-containing DNA template and
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the transcription competent cellular or nuclear extract. Purified fractions of cell or
nuclear lysate were combined in order to find the various protein factors that could
perform transcription on these templates. Through further purification of these fractions,
a minimal set of transcription factors called the ‘general transcription factors’ (GTF) was
identified which could support initiation of transcription from a generic promoter on a
naked DNA template (259). These are TBP (TATA-binding protein), TFIIA, TFIIB, TFIIF,
TFIIE and TFIIH (299). Inside the cell, however, the DNA is organized into a chromatin
structure, which necessitates the requirement of a number of additional factors to
overcome the nucleosomal barrier.
Initiation of transcription begins with the activator-dependent formation of the PIC
on the promoter (Fig. 3). The PIC is formed by the ordered recruitment of the GTFs and
Mediator complex (201). The chromatin remodelers and histone modifiers allow access

of GTFs and RNA polymerase II to the promoter sequence to form PIC. Activatormediated recruitment of general transcription factors on the promoter is facilitated by
Mediator complex. The general transcription factors are recruited in the following order:
SAGA/TFIID, TFIIA, TFIIB, TFIIF along with RNAP II, TFIIE and then TFIIH (36). The
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first factor to be recruited onto the core promoter is either TFIID or SAGA complex. In
general, TATA-less promoters recruit TFIID, and TATA-containing promoters are
dependent on SAGA complex for PIC formation (21, 24, 178, 184, 298). TFIID is
complex composed of TBP (TATA-binding protein) and 14 TBP-associated factors
(TAFs) (108). In yeast, SAGA was originally discovered for its histone H3
acetyltransferase activity (106). It is composed of 6 essential subunits and another 15
non-essential subunits. Five of the six essential subunits, TAF5, TAF6, TAF9, TAF10
and TAF12, are common with TFIID (24, 275, 315). In yeast, TBP binds to the promoter
region at approximately 40-120 bp upstream of the TSS, and creates a bend in the DNA
(Fig. 4) (118). Contrary to the general perception, roughly half of the genes in yeast
contain

TATA-less

promoters

(18).

Current

genomewide

studies

have

revealed

two

mechanisms involved in transcription activation based on the recruitment of either
SAGA or TFIID to the core promoter (138, 170, 181, 184, 185). The two mechanisms
also differ in their requirement for the GTFs necessary to recruit TBP. Promoters
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utilizing TFIID do not depend on Mediator or TFIIB for the recruitment of TBP to the
promoter region, while SAGA-dependent promoters require them to recruit TBP (24-26,
185). TFIIA is a two subunit protein which binds next and stabilizes the TFIID interaction
with the promoter. TFIIA has also been reported to inhibit repressor interaction with
TFIID, thereby promoting transcription activation (213, 218). TFIIB is a single subunit
factor that interacts with TFIID and short regions of DNA flanking the TATA box called
the TFIIB recognition elements (BRE), which function to help position the polymerase at
the correct start site (115, 285). TFIIF is a three subunit factor which is recruited to the
promoter along with RNAP II, and stabilizes its interactions with TFIID and TFIIB (115,
129, 285). Some studies have also implicated TFIIF function in elongation step of
transcription (285). TFIIE is a two subunit factor, which facilitates the recruitment of
TFIIH to the promoter (36). TFIIH is an 11 subunit complex that functions to unwind the
downstream DNA and phosphorylates the CTD of RNAP II (182).
One of the factors that has been found vital for transcription on a wide variety of
promoters is Mediator complex. Mediator has been found to play a critical role in both
activation and repression of transcription (30). Mediator is composed of 25 subunits and
has been found to interact with various gene specific activators (27, 30, 31). It acts as a
bridge between activators and the general transcription machinery (27). Mediator is
therefore often described as a ‘coactivator’ that bridges the link between activator and
the GTFs. Recent studies, however, have found Mediator crosslinking to almost every
RNAP II-transcribed promoter, thereby giving rise to the speculation that Mediator is
indeed a general transcription factor that gets dissociated form the core promoter
immediately after initiation of transcription (308). Mediator complex is divided into 4
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modules: the head, the middle, the tail and the kinase module. The head and kinase
modules interact extensively with RNAP II, TFIID and TFIIH (88, 176, 180). The kinase
module has been shown to inhibit transcription by different methods. First, the Srb10
subunit of the kinase module phosphorylates the CTD of RNAP II before the initiation of
transcription causing a premature release of RNAP II from the PIC (127). Second,
Srb10 phosphorylates TFIIH subunit Ccl1 that is a part of TFIIH-kinase submodule
ultimately resulting in inhibition of kin28 CTD-kinase activity (4). Third, it sterically
interferes with the recruitment of RNAP II to the PIC by making the head module
inaccessible to interact with the polymerase (84, 287). The tail module has been shown
to interact with activators and repressors and regulates recruitment of the transcription
machinery (226). Each of the three subunits in the tail module, when fused to DNA
binding domains, were able to activate transcription even in the absence of an activator
(322). Recent evidence indicates that Mediator is the first transcription factor to respond
to a signal from the activator and is instrumental in initiating the assembly of the PIC at
least on a subset of promoters (308).
Structural studies and biochemical analysis of the PIC have given an insight into
the mechanism of transcription by RNAP II. Following assembly of PIC, unwinding of
about 10 bp surrounding the TSS results in formation of the ‘transcription bubble’ (116).
With the unwinding of DNA, the PIC makes a transition from ‘closed’ to the ‘open’
conformation. The interaction of polymerase subunits with TFIIIF and TFIIB stabilizes
the bubble. TFIIB contains a domain called the B-finger that inserts into the RNA exit
channel of RNAP II (Fig. 7) (200). The B-finger contacts the active site in the enzyme
and helps to correctly position RNAP II at the TSS (Fig. 7). After the synthesis of first 5-
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7 nucleotides, the growing RNA chain begins competing for space with the B-finger in
RNA exit channel and pushes the B-finger out, thereby dissociating TFIIB from the
polymerase (162, 195, 257). Ssl2 subunit of TFIIH now contacts the DNA at about 30 bp
downstream of the TATA-box and unwinds the DNA by a wrench like action (157). Ssl2
helicase activity then extends the bubble downstream. The forward movement of RNAP
II on the template coincides with the collapse of the initiation bubble (238).
Simultaneously, the Kin28 kinase activity of TFIIH phosphorylates RNAP II carboxyterminal domain (CTD) at serine-5 (196). The phosphorylation severs the connection of
polymerase with Mediator, resulting in the release of the complex from the core
promoter (272). This step called ‘promoter escape’ or ‘promoter clearance’ marks the
transition of RNAP II into productive elongation. Following initiation of transcription, a
subset of factors consisting of SAGA/TFIID, TFIIA, TFIIE and TFIIH is left behind on the
promoter forming a ‘scaffold’ that facilitates reinitiation of subsequent rounds of
transcription (325).
1.4 ELONGATION
Transcription elongation begins immediately after promoter clearance, and in
most eukaryotes is accompanied by DSIF (DRB-sensitive inducing factor)-mediated
pausing of RNAP II just downstream of the promoter element (320). Such promoter
proximal pausing of polymerase, however, has not been observed in budding yeast.
The elongation of transcripts on a naked DNA template under in vitro conditions
requires only TFIIF and TFIIS (140). The elongation in yeast is stimulated by the
Ctk1/Bur1, which phosphorylates the CTD of RNAP II at serine-2, and facilitates
recruitment of RNA processing factors (309). A similar role of serine-2 phosphorylation
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has been demonstrated in higher eukaryotes (81). Apart from Mediator, TFIIF is the only
GTF that also plays a role in elongation of transcription by RNAP II (120, 219, 261,
290). The AT-rich sequences in the body of a gene present a barrier to elongation as
RNAP II frequently backtracks on such sequences leading to the misalignment of
growing 3' end of RNA with the active site. TFIIS, a factor that possesses 3’ to 5’
exoribonuclease activity, promotes the release of backtracked RNAP II by realigning the
active site with the 3' end of mRNA (168, 307). Under in vivo conditions, elongating
polymerase has to overcome the nucleosomal barrier. There are three types of factors
that help polymerase move through the chromatin template. These are histone
chaperone, ATP-dependent remodeling factors and histone modifying enzymes. FACT
and Spt6 are histone chaperones for H2A-H2B and H3-H4 respectively (32, 237). They
are essential for smooth passage of polymerase through the chromatin template during
elongation (9, 121, 149). The ATP-dependent chromatin remodelers like RSC and SWISNF complexes have also been shown to overcome nucleosomal barrier in yeast (42,
132). The histone modifying enzymes that are crucial for elongation step are COMPASS
(Complex of Proteins Associated with Set1) and HAT complexes like NuA4 complex
(75, 76, 215). As RNAP II progresses through the body of a gene, the COMPASS
functions to methylate histones at H3K4 near the promoter, which helps recruit other
histone modifying enzymes that acetylate histones in front of the progressing RNAP II.
In turn, this allows for the ATP-dependent chromatin remodeling complexes RSC and
Chd1 along with the histone chaperone FACT to function and allow passage of RNAP II
around the nucleosomal barriers during elongation (183).
1.5 TERMINATION
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Termination is one of the least understood steps of eukaryotic transcription cycle.
Recent studies, however, have begun to shed light on the mechanism of termination of
transcription by RNAP II. Termination requires both cis-acting elements and the transacting termination factors (73, 112, 205, 327). The termination by RNAP II involves
cleavage and polyadenylation of the precursor mRNA, followed by the release of RNAP
II from the template (29). Termination serves a variety of critical functions in the cell.
First, it allows recycling of RNAP II to drive subsequent rounds of transcription. Second,
the addition of a poly(A) tail provides protection to mRNA from 3’ exonucleolytic
cleavage (303). In addition, polyadenylation also improves the translatability of mRNA
(206). Third, termination ensures that RNAP II doesn’t progress further downstream
wasting cellular energy and possibly interfering with the transcription of neighboring
genes (100, 255). Last, proper termination also results in the recruitment of RNA export
factors, which bind the polyadenylated RNA and export it to the cytoplasm for
translation (206).
Termination is coupled to 3' end processing of precursor mRNA. The same set of
factors is required for both the cleavage and polyadenylation of mRNA as well as
dissociation of polymerase from the template (167). In yeast, the termination factors are
organized into three complexes with a combined size of over a megadalton (Fig. 5.)
(216). These are cleavage factor I (CF1) complex, cleavage and polyadenylation factor
(CPF) complex, and the Rat1 complex. The CF1 complex is composed of 5 subunits:
Rna15, Rna14, Pcf11, Hrp1, and Clp1 (109, 152). The CPF complex is composed of 15
subunits: Fip1, Yth1, Pfs2, Pta1, Yhh1, Ydh1, Ysh1, Pap1, Pti1, Ssu72, Glc7, Syc1,
Swd2, Cft1, and Mpe1 (28, 150). The Rat1 complex is composed of 3 subunits: Rat1,
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Rtt103, and Rai1 (198). The names of the CF1 and CPF complexes may be misleading
based on in vitro studies that have shown a requirement for the entire CF1 complex and

the majority of CPF subunits for cleavage and polyadenylation to occur. The Rat1
complex requires the exoribonuclease activity of the Rat1 protein in order to function in
termination (198). Interestingly, export of the polyadenylated mRNA into the cytoplasm
is compromised in mutants of the Rat1 complex (8).
There are two prevailing models explaining the mechanism of termination by
RNAP II: (1) allosteric model, and (2) torpedo model. According to the allosteric model,
there is a change in conformation of the transcription complex as RNAP II transcribes
over the terminator (241). This change causes the release of elongation factors and the
recruitment of termination factors which then bring about termination of transcription.
According to torpedo model, termination is facilitated by the Rat1 exonucleolytic
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complex, which begins degrading the cleaved RNA that is still attached to the
transcribing polymerase at the 3' end of a gene. The Rat1 complex degrades the RNA
until it physically ‘bumps’ into RNAP II (155). This causes a conformational change in
RNAP II and subsequent release from the template. Evidence supports both models,
and the actual mechanism of termination is widely accepted as a combination of both
(198, 249).
1.6 TFIIB: STRUCTURE AND FUNCTION
Transcription factor TFIIB is a single subunit protein of about 38 kDa size. It is
required for initiation of transcription as well as start-site selection. The gene, SUA7,
codes for TFIIB in budding yeast. It was originally discovered in a genetic screen as a
suppressor of a mutation that led to a downward shift in the transcription initiation site
(245). SUA7 is an essential gene in yeast that encodes a protein of 345 amino acids.
Interestingly, the human TFIIB can recruit both human and yeast RNAP II to the
promoter region, while the yeast TFIIB can only recruit the yeast RNAP II, indicating that
an important change has occurred in the structure of protein during evolution (289).
Genetic, biochemical and structural evidence have implicated TFIIB in multiple aspects
of the RNAP II transcription cycle. It has been shown to play a role in activation, PIC
formation, start-site selection as well as the termination of transcription (71, 101, 123,
133).
TFIIB consists of two basic domains, an N-terminal zinc-finger domain, and a Cterminal core domain (Fig 6). The zinc finger domain is known to interact with RNAP II
and TFIIF, while the core domain interacts primarily with TBP as well as the BRE
sequences flanking the TATA-box (37, 114, 316). The core domain of TFIIB, spanning
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residues 120 to 345, is composed of two direct repeats made up of 5 α-helices that are
22% identical and 42% similar, and are separated by an amphipathic helix extending

from 184 to 201 residues (71). The species specific region accounting for the human
and yeast differences has been mapped to 14 residues in the first direct repeat (268). In
vitro, the TFIIB core domain can bind the promoter independently in the presence of
TBP, but is incapable of recruiting RNAP II (14). The C-terminal core domain plays a
crucial role in the initiation of transcription, possibly by helping orient DNA in the
promoter-proximal region for unwinding.
Once the TBP binds the DNA, it bends the DNA by almost 90 degrees (230). The
bend allows interaction of core TFIIB with the BREs upstream and downstream of the
TATA box. The DNA downstream of the TATA-box unwinds in the preinitiation complex
forming the transcription bubble, above the TBP saddle, and the template DNA strand is
positioned at the RNAP II active site (145, 229). TFIIB forms the bridge between the
TBP-TATA box complex and the polymerase surface, where the C-terminal core
interacts with TBP and the N-terminal zing finger makes extensive contacts with Rpb1
and Rbp2 subunits of RNAP II (48, 85, 162, 195, 332).
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Mutational and structural analysis of TFIIB has provided further insight into the
importance of its N-terminal domain. The zinc finger domain can be broken down into
three discrete functional units; the B-ribbon comprising residues 17-55, the B-reader
with residues 56-88, and the B-linker from 89-120 (39, 50, 124, 333). The B-reader is
immediately distal to the N terminal B-ribbon and is the most conserved TFIIB sequence
known (71). It plays a crucial role in start-site selection (123, 187, 239, 246, 330). Two
of the key alleles of SUA7, sua7-1 and sua7-3, which exhibit altered start site selection,
were the consequence of mutations E62K and R78C respectively, mapped to the Breader (246). In addition to start site selection, these mutations also give rise to a coldsensitive phenotype for which suppressors have been isolated. Suppressors of
mutations in this domain were found in TFIIF and RNAP II subunits(277, 278). The
structural studies further confirmed the interaction of B-finger with TFIIF and polymerase
subunits (126). Surprisingly, an enhancer of a mutation in the B-reader was found in
Ssu72, a 3' end processing/termination factor (278).
Structural studies have revealed that TFIIB makes contact with the active site of
RNAP II in the initiation complex (40). The zinc ribbon domain first contacts RNAP II at
the dock domain (40). The residues 20-54 of the zinc ribbon form three antiparallel strands, which surround a zinc ion (Fig. 7). The zinc ribbon domain contacts the RNAP
II at Rpb1 residues 409-419, near the RNA exit channel of the polymerase (16, 37, 114,
133, 321). The TFIIB reader domain passes through the saddle region of RNAP II,
between the clamp and the wall, and inserts into the active center of the enzyme (40).
From there, it extends down to the base of the cleft, and then comes up and exits. In
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addition, the B-finger and core also make multiple contacts with TFIIF, which is located
near the RNA exit channel (41, 94, 126, 200).

TFIIB is essential for initiation of transcription, but immediately after initiation, its
zinc-finger becomes inhibitory for elongation of transcript as it competes with the
growing RNA chain for occupancy of the polymerase saddle region and the exit channel
(238). To allow transcription to proceed further, the zinc finger is ejected from the exit
channel after RNAP II has transcribed first 10-11 nucleotides. This results in the
separation of TFIIB from RNAP II and possibly from the promoter region. In vitro studies
have clearly demonstrated the release of TFIIB from the initiation scaffold soon after
initiation of transcription (325).
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In keeping with its vital role in transcription initiation, TFIIB has been found to
interact both physically and genetically with other components of PIC such as TFIID,
TFIIH and Mediator complex as well as the transcription regulators such as activators
and repressors. TFIIB has been shown to physically interact with TFIID subunits TAF1,
TAF9, TAF10 and TAF12 in the TFIID-TFIIA-TFIIB complex formed on the promoter
during PIC formation (114, 117, 258). TFIIB exhibits physical as well as genetic
interaction with the TFIIH subunits Tfb4 and Ssl2 (105, 295). Mediator subunits Srb2,
Srb5, Srb6 and Rgr1 have been found co-fractionating with TFIIB during
chromatographic purification (197, 325), while

interaction with Med15 subunit was

shown in a split-ubiquitin screen (190).
Reconstituted transcription using purified GTFs, RNAP II and Gal4-VP16 fusion
protein led to the discovery of a novel role of TFIIB in activation of transcription (191,
192). Work from multiple labs has since confirmed the transcription activation function of
TFIIB. In keeping with its role in activation, interaction of TFIIB with a number of acidic
activator proteins has been demonstrated in vitro (71). Most activators have been
shown to interact with the amphipathic helix connecting the two direct repeats in the
TFIIB core domain (1, 45, 172, 186, 316). However, there are some such as VP16 that
interact with the direct repeats (192). A direct physical interaction of TFIIB with the Gal4VP16 activator protein has also been demonstrated in vivo using the crosslinking
approach (117). This is the only known case of a direct physical interaction of TFIIB with
an activator under physiological conditions. In humans, thyroid hormone receptor beta
(THRβ) can function as an activator or repressor depending on whether or not thyroid
hormone is present. It was found that THRβ physically interacts with the N-terminal of
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TFIIB without its hormone ligand and represses transcription. Upon binding of hormone,
THRβ interacted with the TFIIB core domain and activated transcription (15).
TFIIB exists in two conformations, an ‘open form’ where the N and C-termini are
free to interact with other proteins, and a ‘closed form’ where the N-terminal physically
interacts with the second repeat of the C-terminal core (Fig. 8) (14, 101, 122, 124, 250,
317, 331). It has been reported that activators binding to TFIIB induces a change in its
conformation (1, 124, 250, 316). In addition, TFIIB binding to BREs cause a
conformational change that is important for start-site selection (90). Less well known is
the fact that TFIIB can acetylate itself in the presence of acetyl-CoA on Lys238. The
acetylation is important for stabilizing TFIIB-TFIIF interaction, and for transcription in
vitro (54).

1.7 TFIIH: STRUCTURE AND FUNCTION
Transcription Factor TFIIH is a complex of 11 subunits with a molecular mass of
over 500 kDa(224). Apart from Mediator, it is the only GTF with two separate enzymatic
activities: a DNA helicase and a kinase activity (110). TFIIH was discovered in 1989 in
Conaway laboratory when they purified a factor from rat liver that was required for
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accurate transcription initiation and was characterized by an ATPase activity that was
stimulated by the TATA-box (62-64). Structurally, TFIIH can be divided into two
modules: the core module (subunits Ssl1, Ssl2, Rad3, Tfb1, Tfb2, Tfb4, Tfb5 and Tfb6)
and kinase module also known as TFIIK in yeast (subunits Tfb3, Ccl1 and Kin28) (61,
224). Sequencing and structural analysis strongly suggest the evolutionarily conserved
nature of the factor. Electron microscopy (EM) and crystal structure found TFIIH a ring
like structure where TFIIK is linked to the core through Rad3 (Fig. 9) (92, 99, 247, 280).
The

conserved

enzymatic

activities

reside

in

the

Ssl2

and

Rad3,

which are 3’ to 5’ and 5’ to 3’ ATP-dependent helicases respectively; and Kin28 which is
a serine kinase that phosphorylates CTD of Rpb1(61). In yeast, the Ssl1 subunit has
also been found to contain an E3 ubiquitin ligase activity that functions in the
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transcriptional regulation of genes involved in DNA repair (281). Apart from its essential
function in transcription, TFIIH has also been found to play a crucial role in the repair of
DNA by nucleotide excision repair (NER) pathway. A few studies have also implicated
TFIIH in RNAP I transcription (13, 33, 77, 139, 260).
During transcription, the enzymatic activities of TFIIH play key roles in
stabilization of PIC and in promoter escape (308). TFIIH is the last GTF to be recruited
onto the promoter during PIC formation. It is not necessary for transcription in an in vitro
transcription system when the template DNA is either supercoiled or partially melted
near the TATA-box (135, 242). The core module forms a ring like structure that
positions the Ssl2 helicase at the leading edge in front of the PIC and RNAP II, and the
Rad3 helicase behind RNAP II. It is through this positioning that both helicases could
function where Ssl2 will unwind the DNA in 3’ to 5’ direction from the leading edge
toward RNAP II while Rad3 may unwind from the back in 5’ to 3’ orientation, melting the
DNA and extending the transcription bubble with RNAP II (99). However, it is only the
Ssl2 helicase activity that is required for formation of the open complex where 10 bp of
DNA is melted just downstream of the TATA box (56, 57). Recent work indicates that
Ssl2 may not function in the PIC as a 3’ to 5’ helicase and instead works as a DNA
translocase. It was found that Ssl2 binds downstream of the bubble and may insert 15
bp of unwound DNA into the RNAP II active site (57, 111, 157).The requirement of Ssl2
helicase continues during initiation until the bubble reaches 17-18 bp and collapses
back down to 10 which is the size during elongation (238).
The exact contacts that different subunits of TFIIH make during PIC formation
are not well understood as the structural studies on TFIIH are not of high enough
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resolution to map them into the RNAP II EM densities. Recently, Tfb6 was identified as
the 11th subunit of TFIIH. It was found that Tfb6 interacts with Ssl2 and this interaction
dissociates Ssl2 from TFIIH holoenzyme upon Tfb6 phosphorylation. Tfb6 is not an
essential protein and purification of TFIIH from a Tfb6 deleted strain resulted in a 20 fold
increase in yield of holo-TFIIH complex (224).
TFIIH kinase activity is stimulated by interactions with TFIIE, TFIIF and the
Mediator along with the U1 snRNA (22, 88, 171, 233, 236). TFIIK phosphorylates RNAP
II CTD at both serine-5 and serine-7 in the open complex, although in yeast it is unclear
exactly where this happens in vivo as RNAP II scans downstream for about 20- 200 bp
in order to find a TSS, which is well past the size of the bubble (3, 103, 199). This is in
contrast to mammalian cells, where TSS is generally located 23-28 bp downstream of
the TATA-box (86). The CTD phosphorlyation signals promoter escape and also breaks
the contacts of Mediator head module with RNAP II CTD. The serine-5 phosphorylation
mark then signals the recruitment of the capping machinery (53, 89). After the first
round of initiation, TFIIH remains on the scaffold with TFIID, TFIIA and TFIIE in the
presence of an activator in order to drive further rounds of reinitiation (325).
1.8 CTD PHOSPHORYLATION
The largest subunit of RNAP II, Rpb1, contains a region towards the C-terminus
called the carboxy-terminal domain (CTD), which consists of multiple repeats of the
heptapeptide sequence Y1S2P3T4S5P6S7. Since its discovery in 1985, it has been a focal
point of research (65, 66). The CTD repeats are highly conserved in sequence yet vary
in number from organism to organism. There are 26 repeats in yeast, 46 in flies and 52
in human (35, 65). Deletion of the CTD is lethal in vivo, but not required for in vitro
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transcription (231, 232, 328). The CTD is the target for many post translational
modifications. Five of its seven residues, tyrosine-1, serine-2, threonine 4, serine-5 and
serine-7, can be phosphorylated (Fig. 10). In addition, the proline residues at 3 and 6
can be isomerized into stable cis and trans configurations (81).

In order to better

understand the possible syntax of the CTD, research done in the Stiller and Shuman
laboratories placed additional residues at key places throughout the CTD (193, 263,
276).

The results indicate that the CTD is actually composed of 11 residues long functional
units, which comprises the first heptad and the next four residues in the chain (81, 194,
262, 276). Taken together, it would appear that the overall length of the CTD is
important, along with keeping functional units intact with respect to tyrosine and serineproline-serine spacing. In yeast, with 26 repeats, the overall length of an unordered
CTD tail could stretch up to 900 Ao, which is nearly 6 times the diameter of RNAP II;
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making it an ideal scaffold to recruit factors that need to physically interact with RNAP II
over a variety of its surface during transcription and cotranscriptional RNA processing
(81).
The enzymes responsible for most of the CTD posttranslational modifications
have been discovered. In yeast, there are four known enzymes for phosphorylating the
CTD: Kin28, Srb10, Ctk1 and Bur1. Kin28 is a subunit of TFIIH that performs serine-5
and ser7 CTD phosphorylation (103, 156). Srb10 is a subunit of Mediator and has been
shown to phosphorylate serine-2 and serine-5 in vitro (127, 188). Ctk1 is a subunit of
the elongation complex and is thought to perform the majority of serine-2
phosphorylation (52). Bur1 functions during elongation as part of the Bur1-Bur2 cyclindependent kinase complex and phosphorylates serine-2 and serine-5 in addition to
phosphorylating the elongation factor Spt5 (309). In budding yeast, three more kinases
that could possibly target the CTD have been identified on the basis of their
phosphorylation target similarity with known CTD kinases. These are Brd4, Erk1 and
Erk2 (81). It is thought that Brd4 may be a yet another kinase that may target serine-2.
The CTD phosphorylation at tyrosine-1 and threonine-4 residues was recently
demonstrated in yeast. However, identification of the kinases responsible for these
modifications remains elusive (47, 130, 137). The prolyl-isomerase, Ess1, preferentially
targets the proline-6 residue when serine-5 is phosphorylated and has been shown to
be involved in initiation and termination of transcription (119, 163).
The serine phosphatases that remove CTD mark are well characterized. Ssu72,
which is a component of the cleavage and polyadenylation factor (CPF) complex,
removes serine-5 and serine-7 marks (19, 95, 165). Ssu72 is recruited at the promoter
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and the terminator regions of a gene and is believed to function at both the ends of a
gene (10). Cdc14 removes both serine-2 and serine-5 marks and functions during
mitosis where it is required for mitotic exit (55). Rtr1 is a serine-5 phophatase that has
been shown to function during the transition from initiation to elongation (220). Fcp1 is a
serine-2 phosphatase which is also recruited at the promoter and terminator regions,
but is only thought to function at the terminator (160).
Early ChIP experiments using some of the first antibodies to recognize CTD

phosphorylation began to paint the picture of a CTD code that could be used to tell the
position of RNAP II along a gene. In this now widely accepted model for protein coding
genes, serine-5 phosphorylation peaks over the TSS and fades along a gene in a
fashion opposite to that of serine-2 phosphorylation which starts downstream of the
promoter and peaks over the poly(A)-site (Fig. 11) (35). Tyrosine-1 and threonine-4
phosphorylation remains at high levels throughout the coding region between the
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promoter and the terminator. Serine-7 phosphorylation exhibits a similar pattern, except
that it extends a little bit more into the promoter and terminator regions (81). The CTD
phosphorylation pattern over a gene signals the stage of transcription of a gene. The
initiation factors, such as Mediator and TFIIH, involved in PIC assembly, recognize
hypophosphorylated CTD (158, 308). A notable exception is that some of the
termination factors, such as Pcf11 and Ssu72, thought to be recruited through serine-2
phosphorylation at the terminator, are also recruited onto the promoters (6, 266).
More recently, numerous genomewide data sets have attempted to analyze this
problem with new monoclonal antibodies that can better detect specific CTD
phosphorylation patterns. These studies have revealed that different genes exhibit
different patterns of CTD phosphorylation during transcription. A recent study found that
the pattern of CTD phosphorylation differed on genes depending on their transcriptional
activity and their isolation within the genome (286). Some genes displayed a more or
less uniform serine-2, serine-5, and serine-7 phosphorylation pattern throughout the
gene body. In contrast, some have only 5’ or 3’ phosphorylation peaks, while others
have both 5’ and 3’ peaks of a particular modification. For example, some genes display
a uniform serine-7 phosphorylation pattern throughout the gene, while a number of
genes exhibit only the 5' enrichment (286). For the serine-5 phosphorylation mark, most
genes displayed only a 5' peak, while some showed a peak at both the 5' and 3' ends.
Regarding the serine-2 phosphorylation mark, while most genes conformed to the usual
model with a 3’ peak, they did find those that either had uniform or 5’ peak distributions
(286).
1.9 PROMOTER-TERMINATOR CROSSTALK
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The transcription cycle can be divided into three basic steps: initiation, elongation
and termination. Each of these steps requires a unique set of factors for its proper
execution. The generally accepted view is that the transcription factors have exclusive
roles dedicated to a particular step in the transcription cycle. The current body of
evidence suggests that the different steps of the transcription cycle do not operate in
isolation, but rather integrate into each other (167, 203, 212, 266, 297). This may seem
intuitive for sequential steps where some initiation factors also participate in elongation,
as the subsequent elongation step relies on completion of initiation. However, evidence
suggests that the initiation factors may function in termination, and termination factors
similarly help in initiation of transcription (6, 115, 207, 212, 221, 329). This promoterterminator crosstalk is poorly understood, and it is not known how these functional
relationships can influence the transcription cycle.
There are a number of factors operating at the promoter region of eukaryotic
genes that physically or functionally communicate with the terminator-bound factors
(Table 1). TFIIB, for example, interacts with a number of termination factors. These
include both genetic and physical interactions. The first evidence regarding this
TABLE 1 Promoter bound factors which interact genetically or physically with
terminator bound factos
Promoter
bound
Factor
TFIID

Protein /
subunit

Terminator
bound Factor

Taf2

CPF

Taf5

CPF

Interacting
partner/subu
nit
Ssu72, Fip1,
Cft2, Cft1,
Mpe1, Ref2,
Ysh1, Pta1,
Pap1
Cft1

Type of
interaction

Reference

Affinity-MS

Sanders et al.,
2002

Affinity-MS

Lee et al.,
2011
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Taf6

TFIIB

TFIIH

Mediator

Pab1

Affinity-MS

Sanders et al.,
2002

Taf6

3'-end RNAprocessing
complex
CF1

Rna14

Affinity-MS

Taf8, Taf12

Rat1 complex

Rtt103

(-) Genetic

Taf9

CPF

Ref2

Synthetic lethal

Taf14

Isw1b

Ioc2

(+) Genetic

TFIIB

CPF

Ssu72

TFIIB

CPF

Ssu72

TFIIB

CPF

Ssu72

TFIIB

CPF

Ssu72

Phenotypic
enhancement,
Synthetic rescue
Dosage rescue,
Synthetic lethal
Reconstituted
complex
Affinity-Western

Gavin et al.,
2002
Constanzo et
al., 2010
Milgrom et al.,
2005
Collins et al.,
2007
Sun and
Hampsey 1996

Rad3

CF1

Rna14

Synthetic rescue

Ssl1

Rat1 complex

Rtt103

(-) Genetic

Kin28

CPF

Ssu72

Med8

Rat1 complex

Rtt103

Affinity-Western,
Synthetic lethal
(-) Genetic

Rox3

Yra1

Affinity-MS

Srb2

(3'-end RNAprocessing)
CPF

Ssu72

(-) Genetic

Med1

CPF

Syc1

(-) Genetic

Soh1

CPF

Ssu72

(-) Genetic

Soh1

CPF

Syc1

(-) Genetic

Soh1

Rat1 complex

Rtt103

(-) Genetic

Gal11

CPF

Swd2

(-) Genetic

Gal11

Rat1 complex

Rtt103

(-) Genetic

Pgd1

Rat1 complex

Rtt103

(-) Genetic

Pgd1

Isw1b

Ioc4

(+) Genetic

Cse2

CPF

Syc1

(-) Genetic

Sin4

Rat1 complex

Rtt103

(+) Genetic

Sin4

Isw1b

Ioc2

(-) Genetic

Wu et al., 1999
Wu et al., 1999
Ganem et al.,
2003
Jensen et al.,
2004
Constanzo et
al., 2010
Ganem et al.,
2003
Constanzo et
al., 2010
Krogan et al.,
2006
Constanzo et
al., 2010
Wilmes et al.,
2008
Collins et al.,
2007, Fielder et
al., 2009
Wilmes et al.,
2008
Wilmes et al.,
2008
Collins et al.,
2007
Collins et al.,
2007
Collins et al.,
2007
Collins et al.,
2007
Wilmes et al.,
2008
Costanzo et
al., 2010
Costanzo et
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SAGA

Srb5

CF1

Rna15

Affinity-Western

Gcn5

CPF

Ysh1

Affinity-MS

Ada2

CF1

Pcf11

2 Hybrid

Ahc1

Isw1b

Ioc4

(-) Genetic

Spt8

CF1

Rna14

Spt8

CPF

Pti1

Synthetic growth
defect
(-) Genetic

Spt8

CPF

Ssu72

(-) Genetic

Spt8

CPF

Pta1

(-) Genetic

Ubp8

Rat1 complex

Rtt103

Synthetic rescue

Spt3

CPF

Pta1

(-) Genetic

Spt3

CPF

Pti1

(-) Genetic

Spt3

Rat1 complex

Rtt103

(-) Genetic

Chd1

Isw1b

Ioc2

(-) Genetic

Chd1

Isw1b

Ioc4

(-) Genetic

Ngg1

Pab1

Affinity-Western

Sgf29

3'-end RNAprocessing
complex
CPF

Pta1

(-) Genetic

Hfi1

Isw1b

Ioc2

(-) Genetic

Spt7

CPF

Cft1

Affinity-MS

Sus1

(3'-end RNAprocessing)
(3'-end RNAprocessing)

Yra1

Affinity-Western

Yra1

Synthetic lethal

CF1

Pcf11

(+) Genetic

Sus1
Sgf73

al., 2010
Mukundun et
al., 2013
Graumann et
al., 2004
Uetz et al.,
2000
Costanzo et al.,
2010
Holbien et al.,
2009
Collins et al.,
2007
Collins et al.,
2007
Collins et al.,
2007
Hang et al.,
2011
Collins et al.,
2007
Collins et al.,
2007
Collins et al.,
2007
Collins et al.,
2007
Costanzo et al.,
2010
Drysdale et al.,
1998
Costanzo et
al., 2010
Collins et al.,
2007
Lee et al.,
2011
Pascual-Garcia
et al., 2008
RodriguezNavarro et al.,
2004
Costanzo et al.,
2010

came from a genetic screen for factors important for initiation. A point mutation (E62K)
in the B-finger region of yeast TFIIB (sua7-1) altered transcription start site selection
and conferred a cold-sensitive growth phenotype (246). A mutation in Ssu72 (ssu72-1)
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enhanced this defect by shifting the start site further downstream and conferring a heatsensitive phenotype (278). Yeast proteomic analysis identified Ssu72 as a subunit of the
CPF complex (72, 97, 125, 274). In addition to the genetic interaction, TFIIB and Ssu72
also exhibit a physical interaction in vitro (317). These observations raised the intriguing
possibility that TFIIB could be making additional contacts with the components of the 3’
end processing machinery during transcription. These studies strongly suggested a role
for TFIIB at the 3′ end of genes, and will be the focus of investigation in Aim# 1 of my
thesis.
In addition to TFIIB, there are also reports of TFIIH interaction with termination
factors (Table 1). Several subunits of TFIIH have been found physically and functionally
interacting with the 3′ end associated factors. Kin28, which is the kinase subunit of
TFIIH, interacts physically as well as genetically with Ssu72 (67, 97, 115, 165). The
TFIIH-Ssu72 interaction as well as phosphorylation-dephosphorylation of serine-5 and
serine-7 contribute to successful execution of the transcription cycle and will be
discussed later in this chapter in the context of Ssu72. In addition to the Kin28-Ssu72
interaction, Ssl1 subunit was found to exhibit a genetic interaction with Rtt103 subunit of
Rat1 complex, which is involved in termination of transcription (67, 155). The role of
these interactions and TFIIH kinase activity at the 3’ end of genes will be the focus of
investigation in Aim# 2.
Mediator is another promoter-associated factor that exhibits interaction with the
terminator-bound factors. The first evidence that Mediator could be contacting the
termination factors came from a large scale yeast proteomic analysis (58). This study
identified interaction of one of the head subunits, Rox3, with Yra1, a protein involved in
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3′ end processing and mRNA export (Table 1). All other Mediator-termination factor
interactions that have been reported so far are from the widely used ‘Epistatic Miniarray
Profile’ (E-MAP) technology, which measures genetic interactions based on the pairwise deletion of genes that have been linked to specific biological processes. This
synthetic genetic approach established interaction of the head subunit, Med8, with
Rtt103 (58), and identified further interaction of middle and tail submodules with the
CPF subunits (Table 1) (58, 67, 306). Recently, Srb5 subunit of Mediator head module
was also found interacting with the Rna15 subunit of CF1A complex (221)(Mukundan
and Ansari, 2013).
The overwhelming evidence of the interaction of the promoter and terminatorbound factors in the cell raises an important question. What is the significance of such
interactions in the context of the transcription cycle? A clue came from crosslinking
studies

of

the

factors

on

transcriptionally

active

genes.

The

chromatin

immunoprecipitation (ChIP) analysis of formaldehyde-crosslinked cells revealed that the
initiation and termination factors are not merely interacting with each other, but they are
also interacting with the distal ends of genes (Fig. 12). TFIIB, for example, has been
found occupying both the 5′ and 3′ ends of genes during transcription (83, 209, 210,
212, 225, 270, 293). A genomewide analysis revealed that about 80% of a selected
group of 1140 transcriptionally active genes in yeast have TFIIB localized at both ends
(225). The TFIIB signal at the 3′ end, however, was 2-times less than that on the 5′ end.
The crosslinking of TFIIB to the extremities of genes during transcription is an
evolutionarily conserved feature, being observed in humans as well (207, 323). A similar
gene occupancy profile has been observed for TBP, both in yeast and humans (207,
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225). Mediator subunit Srb5, TFIIF subunit Tfg1, as well as TFIIH subunits; Ssl2

and Kin28, also occupy the distal ends of a gene in a transcription-dependent fashion
(105, 210, 221, 248, 329). The transcription-dependent interaction of so many initiation
factors with the 3′ end strongly suggests a biological role for these factors at the
terminator end of genes.
Analogous studies with the termination factors found them localized to the 3′ end
as expected, but a number of them were also found occupying the 5′ end of genes (Fig.
12). The subunits of both CF1 and CPF complexes in yeast exhibited the transcriptiondependent crosslinking to gene boundaries (10, 43, 155, 212, 227). A similar
localization of CPSF and CstF subunits at the ends of genes was observed in
mammalian systems (102, 297). Recently, crosslinking of two termination factors, TTF2
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and Xrn2, to the 5′ end of genes was reported in mammalian cells (34). The homologue
of Xrn2 in yeast is Rat1. Both Rat1 and Xrn2 are believed to facilitate termination of
transcription by the torpedo mechanism (155, 302). The Rat1 and its associated factor
Rai1 also occupy both ends of genes during transcription (155).
One possible explanation for termination factors occupying the promoter region
arose from the recent discovery of wide spread promoter driven upstream anti-sense
transcription (240, 264, 265). Many of these short anti-sense transcripts were found to
be cleaved and polyadenylated poly(A) signals (7). Interestingly, the U1 signals were
found to be enriched in the sense direction relative to the poly(A); and the disruption of
U1 snRNP activity resulted in the premature termination in the sense direction (7). Thus,
the interaction of the initiation and termination factors is not merely the coincidental corecruitment to the distal ends of a gene, but indicates a functional relationship that
confers directionality to the promoter-bound polymerase and also influences overall
transcription of a gene. Another possible interpretation of this evolutionarily conserved
transcription factor occupancy pattern on gene extremities is that the initiation and
termination factors may physically interact with each other on the chromatin template
during transcription to form a gene loop that enhances efficiency of transcription.
1.10 GENE LOOPING
The ChIP data, along with the physical interaction data and the genetic analysis,
have provided unequivocal evidence in support of the interaction of a number of
initiation and termination factors with both the ends of a gene. A critical issue is how the
initiation and termination factors that are expected to occupy the 5′ and 3′ ends
respectively of a gene, are able to contact both ends of a gene. There are two possible
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explanations for this rather unexpected distribution of transcription factors. One
possibility is that these factors are recruited independently to both ends of a gene. The
other possibility is that the presence of a factor at the two ends of a gene is the result of
gene

looping

(102)

(Fig.

13).

When

a

gene

is

in

looped

conformation, the close proximity of the promoter and terminator regions may facilitate
the interaction of a promoter-bound factor with the terminator region, and that of a
terminator-associated factor with the promoter. There is a high probability that the same
molecule simultaneously contacts both ends of a looped gene (270). In such a scenario,
the molecules occupying the promoters and terminators are not separate entities (Fig.
13). There is experimental evidence to support both possibilities (23, 102, 173, 207,
221, 270, 293).
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A number of genes in yeast undergo looping in a transcription-dependent manner
(6, 10, 23, 83, 102, 141, 217, 270, 283, 284). Chromatin analysis using the
chromosome conformation capture (CCC) approach revealed that gene looping is due
to the juxtaposition of the promoter and terminator regions of a gene (Fig. 13). When a
gene is in looped conformation, TFIIB localizes to both ends of the gene (83, 270).
Gene looping is completely abolished in the sua7-1 mutant (E62K) of TFIIB in budding
yeast. This is the same mutant that led to the discovery of one of the first known
interactions of a promoter-bound factor with a terminator-linked factor, that of TFIIB with
Ssu72 (102, 278). In this mutant, the recruitment of TFIIB at the promoter region
remains unaffected, but its crosslinking to the 3′ end of a gene is almost completely
abolished (270). Accordingly, TFIIB-interacting termination factors were observed at the
5′ end of a gene in wild type cells, but not in the looping defective sua7-1 cells (6).
Although the concept of gene looping is not so well established in higher eukaryotes,
analogous studies have found evidence of genes assuming a looped architecture during
transcription in mammalian systems as well (141, 179, 234, 243, 282, 326). There are
also reports of transcription dependent gene looping in Drosophila and plants (70, 128).
Gene looping explains localization of at least some transcription factors at the distal
ends of a gene. The crosslinking of TFIIB, Mediator subunit Srb5 as well as TFIIH
subunits; Ssl2 and Kin28 to both the ends of a gene in yeast occurs in a looping
dependent manner, and therefore can be attributed to gene looping (83, 105, 210, 221,
248, 270, 329). Similarly, a number of CF1 and CPF subunits in yeast also crosslink to
the promoter region in a looping-dependent manner (6, 10, 43, 155, 212, 227).
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Gene looping, however, may not account for the interaction of all initiation and
termination factors with the ends of genes. A substantial number of yeast genes exhibit
anti-sense transcription initiating from their 3′ end (49, 228, 318). The genes with
detectable 3' end initiated anti-sense transcripts display a promoter-like architecture at
their 3′ end (225). Genomewide analysis revealed that a majority of such genes have
TFIIB and TBP present at their 3′ end (225). Whether these genes assume looped
conformation during anti-sense transcription remains to be elucidated, but at least some
of them display anti-sense transcription as well as the TFIIB-TBP occupancy at the 3′
end in the absence of gene looping (225). The interaction of TFIIB and TBP with the 3′
end of genes in linear conformation, therefore, cannot be attributed to gene looping, but
to the independent recruitment of these factors at the 3′ end of genes.
The physiological significance of gene looping has been recently demonstrated in
a few key studies. First, gene looping was found to play a role in transcriptional
memory, which is the process where the transcriptional machinery ‘remembers’ a
previously activated state via gene loop formation, and thus the cell can respond much
faster during reinduction (173, 283). Second, gene looping was linked to promoter
directionality, where promoter driven anti-sense transcription decreased during gene
loop formation (44, 284). Third, the intron-mediated enhancement of transcription (IME)
has been found to require gene loop formation, and the addition of an intron to the 5’
proximal coding region can activate a gene and force a looped conformation (217).
Fourth, gene looping helps in activator dependent enhancement of transcription by
facilitating reinitiation (6, 83). Last, gene looping has also been shown to facilitate
termination of transcription, possibly through the poly(A) site selection (6).
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1.11 RESEARCH FOCUS
While the prevalence and physiological significance of gene looping has been
demonstrated over the last decade; the mechanism that physically links the promoter
and terminator regions in order to form a gene loop is poorly understood. It is
hypothesized that gene loops form due to the interaction of promoter and terminator
bound factors. Namely, the general transcription factors (Mediator, TFIID, TFIIA, TFIIB,
TFIIF and TFIIH) would physically and functionally interact with the termination factors
(CF1 and CPF). In order to investigate if that is the case, my research focused on two of
the general transcription factors: TFIIB and TFIIH.
TFIIB was an excellent candidate based on its localization on the terminator
during transcription, its genetic interaction with the termination factor Ssu72 and the loss
of gene looping in the mutant of TFIIB, sua7-1. In chapter II, my research focuses on
investigating the molecular basis of gene loop formation through the isolation of a gene
looping complex with TFIIB. Genome wide studies have also demonstrated that in
addition to TFIIB, TFIIH localizes on the terminator (248, 292, 294). In chapter II, my
research investigates a role for TFIIH in the termination of transcription and gene loop
formation. In addition, I further demonstrate that these roles are dependent on the
kinase function of TFIIH subunit, Kin28.
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CHAPTER II
EVIDENCE FOR A HOLO-TFIIB COMPLEX CONTAINING TERMINATION FACTORS
THAT FACILITATE GENE LOOP FORMATION

Most of this chapter has been published:
Medler et al., (2011) Evidence for a Complex of Transcription Factor IIB (TFIIB)
with Poly(A) Polymerase and Cleavage Factor 1 Subunits Required for Gene
Looping. J Biol. Chem. 286:33709-18. DOI: 10.1074/jbc.M110.193870
II.1. ABSTRACT
Gene looping is emerging as an important gene regulatory mechanism in
eukaryotes. The presence of general transcription factors at the promoter region of a
gene during transcription is well established. However, recent studies have revealed the
localization of the general transcription factor TFIIB to the 3’ end of a gene as well
during transcription. Here we show that TFIIB localization at the terminator end of a
gene requires a functional CF1 complex. TFIIB physically interacts with the all subunits
of the CF1 complex. Affinity chromatography and sedimentation analysis revealed the
existence of a holo-TFIIB complex consisting of Pap1 and CF1 subunits. This complex
was resistant to MNase digestion suggesting that the interaction of TFIIB with
termination factors was not mediated by RNA or DNA. The complex was also stable
upon brief exposure to high salt. The sedimentation coefficient of the holo-TFIIB
complex was similar to that of large ribosomal subunit, and was intermediate between
that of TFIIH and TFIID. The general transcription factors TFIID and TFIIH as well as
subunits of RNAP II could not be detected in the affinity-purified holo-TFIIB preparation.
The holo-TFIIB complex was observed only in the looping competent strains, but not in
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the looping defective sua7-1 strain. We further show that in sua7-1 cells, where a holoTFIIB complex is not formed, the kinetics of activated transcription are altered. These
results strongly suggest a role for the holo-TFIIB complex in gene looping, and a
possible role of gene looping in activator-dependent transcription.
II.2. INTRODUCTION
Transcription of protein encoding genes by RNA polymerase II (RNAP II)
involves several distinct steps that include the assembly of preinitiation complex,
initiation, elongation, termination, and reinitiation (115, 310). Transcription starts with
the recruitment of RNAP II and the general transcription factors TFIID, TFIIB, TFIIA,
TFIIF, TFIIE, and TFIIH onto the promoter to form a preinitiation complex (PIC) in
response to a signal. Gene specific activators respond to the signal by facilitating the
assembly of PIC. RNAP II and general transcription factors are sufficient for accurate
basal level transcription at least under in vitro conditions (252, 314). The response to
activators requires additional cofactors that include chromatin modifiers and Mediator
complex. Once the gene is activated, the amount of transcripts produced is determined
primarily by the number of reinitiation events (74). Despite the remarkable progress
made in understanding the molecular mechanisms that govern initiation of transcription
in eukaryotes, relatively little is known about the processes that mediate reinitiation. It
was hypothesized that efficient transfer of polymerase from the terminator to the
promoter is facilitated by a DNA loop between distal ends of the transcribed gene (74,
169). The existence of such gene loops has been recently reported for RNAP IItranscribed genes in yeast, plants and mammalian cells (10, 234, 235, 243, 282). It has
been shown that RNAP II-dependent gene looping is the consequence of the physical
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interaction of the terminator with the promoter of the same gene during transcription.
Gene looping has been shown to require both the cis acting poly(A) termination signal
and the trans acting 3’ end processing/termination factors (10, 243). The general
transcription factor TFIIB, which exhibits a genetic interaction with the CPF subunit
Ssu72, was also found essential for gene looping in yeast (270). Whether termination
factors and TFIIB facilitate transfer of RNAP II from the terminator to the juxtaposed
promoter is not known.
The emerging ubiquity of gene looping and its potential as an important
transcription regulatory mechanism necessitates understanding the mechanism of gene
loop formation. Our hypothesis is that the looped architecture is formed by the
interaction of promotre-bound factors with the factors occupying the 3' end of the gene.
The preliminary results produced in our laboratory and the published reports have
identified TFIIB is an important determinant of gene looping. We therefore searched for
the TFIIB interacting termination factors in this investigation. We believe that a
macromolecular complex containing TFIIB and the termination factors may serve as a
bridge between the promoter and the terminator regions during gene loop formation.
II.3. RESULTS
II.3.1. ACTIVATORS INTERACT WITH TFIIB DURING ACTIVATED TRANSCRIPTION
Activators bring about enhancement of transcription. Recent evidence from our
laboratory suggests that the activator-dependent stimulation of transcription is
dependent on gene looping. However, activators do not interact with the 3′ end of the
gene during loop formation (83). These results imply that the activators may be
facilitating gene looping by recruiting other factors that interact with both the 5' and the
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3' ends of a gene. We have also shown that TFIIB is an important determinant of gene
looping. These observations suggest that activator may be enhancing transcription
through TFIIB-mediated gene looping.
A number of transcription activators in yeast, mammalian systems and plants
have been shown to physically interact with TFIIB (71). In many of these studies, an
activator-TFIIB interaction was demonstrated in the absence of transcription. None of
the studies in yeast demonstrated physical contact of a native activator with TFIIB under
in vivo conditions. The vast majority of interactions were performed using in vitro protein
binding assays which demonstrated that the activators were interacting with the two
direct repeats in the C terminus of TFIIB which also is shown to interact with RNAP II.
The only in vivo evidence of a physical interaction is the crosslinking of a Gal4-VP16
fusion construct with TFIIB during induced transcription (117). If the activators bound to
their UAS site are mediating gene looping through their interactions with TFIIB, we
expect activator-TFIIB interaction to occur only during activated transcription when the
gene is in a looped configuration.
To investigate interaction of TFIIB with activators, we chose Met28, Ino2 and
Gal4, which are the gene specific activators of MET16, INO1, and GAL1p-BUD3,
respectively. Transcription of MET16 is regulated by methionine. In the presence of
methionine, MET16 is transcribed at a very low level. However, upon methionine
depletion, transcription of MET16 is stimulated by about 5-fold (83). Similarly,
transcription of INO1, a gene involved in inositol metabolism, is enhanced by about 50fold in the absence of inositol in the medium (83). GAL1p-BUD3, as we have shown
earlier, is almost completely repressed in the presence of dextrose as a carbon source
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(83). The addition of galactose brings about a 50-fold stimulation of transcription of
GAL1p-BUD3 (83). All these three genes are in a looped conformation during their
induced transcriptional state. In the absence of activators, both gene looping and
enhanced transcription of these genes is severely compromised.
We therefore performed coimmunoprecipitation with anti-HA antibodies in strains
with HA-tagged Met28, Ino2, and Gal4. Coimmunoprecipitation was done during
induced and non-induced states of MET16, INO1, and GAL1p-BUD3 in formaldehyde
crosslinked cells. There was no interaction of TFIIB with Met28, Ino2, and Gal4 under
non-induced conditions (Fig. 14, lanes 3, 8, and 13). TFIIB was coimmunoprecipitated
with the activators only under transcriptionally inductive conditions (Fig. 14, lanes 5, 10,

and 15). Activator-TFIIB interaction was not mediated by DNA because micrococcal
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nuclease digestion of DNA did not abolish the interaction (Fig. 14, lanes 4, 9, and 14).
The complete digestion of chromatin by micrococcal nuclease was routinely checked
before performing the coimmunoprecipitation (Figure 15). A moderate decrease in Gal4-

TFIIB interaction was often observed in the absence of DNA. This suggested that Gal4
may be interacting with TFIIB through DNA under certain conditions. However, a
reproducible Gal4-TFIIB interaction was always observed in the absence of DNA (Fig.
14, lane 14). These results demonstrate that an activator-TFIIB interaction occurs
specifically during activated transcription in vivo.
II.3.2. TFIIB localization on the terminator region requires Pap1, Rna14 and Pcf11,
but not Hrp1
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Having shown the activator-TFIIB interaction during gene loop formation, we next
investigated how TFIIB is facilitating gene looping. We reasoned that the promoterbound TFIIB may be interacting with the factors present at the 3' end of the gene, and
this interaction will bring the terminator and the promoter in close physical proximity.
Our reasoning was based on three published results. First, TFIIB is known to exhibit
genetic interaction with Ssu72, a component of CPF 3’ end processing complex (278).
Second, it has been recently demonstrated that TFIIB occupies both the promoter and
terminator regions of PMA1 and BLM10 in an Ssu72-dependent manner (270). Third,
looping of several yeast genes was abolished in sua7-1, a mutant of TFIIB that is
defective in gene looping (270). Since TFIIB physically interacts with several gene
specific activators in a transcription dependent manner, it was therefore a strong
candidate for the factor mediating activator-dependent gene looping.
We therefore asked whether TFIIB association with the 3’ end of genes is also
dependent on termination factors such as Rna15, Rna14, Pcf11, Hrp1 and Pap1. TFIIB
ChIP was therefore performed for MET16 and INO1 genes in the temperature-sensitive
mutants of Rna15 (rna15-2), Rna14 (rna14-1), Pcf11 (pcf11-2), Hrp1 (hrp1-5), Pap1
(pap1-1) and isogenic wild type strains. TFIIB-ChIP was performed under induced
transcriptional state of a gene at the permissive (25°C) and non-permissive (37°C)
temperatures of the mutants. TFIIB crosslinked to both the ends of INO1, in the wild
type strain at 25°C and 37°C during induced transcription (Fig. 16). In contrast, TFIIB
crosslinking to the terminator was abolished in rna15-2, rna14-1, pcf11-2 and pap1-1
strains at restrictive temperature (37°C) (Fig. 16), while the crosslinking to the promoter
remained intact (Fig. 16). Remarkably, TFIIB occupancy of the terminator region of
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INO1 remained unaffected in hrp1-5 strain following a temperature shift to 37°C (Fig.
16).

Identical results were obtained with MET16 (Fig. 17). Thus, Rna15, Rna14, Pcf11 and
Pap1 are required for interaction of TFIIB with the 3’ end of MET16 and INO1. Hrp1 may
not be required for TFIIB localization to the terminator regions of genes.
II.3.3. TFIIB forms a complex with CF1 subunits and Pap1
TFIIB is an essential general transcription factor (71). Recombinant TFIIB, with a
molecular weight in the range of 32 to 38 kDa, could complement all functions of native,
biochemically purified TFIIB in an in vitro transcription assay (113, 204, 244, 288).
These results suggested that TFIIB is a single polypeptide protein that exists as a
monomer in solution. There was no evidence of TFIIB being a part of a macromolecular
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complex containing initiation factors or termination factors or any other protein. To find
proteins associated with TFIIB under physiological conditions, the proteomic analysis
was performed employing the TAP-approach (96, 97, 166). Neither a promoter nor a

terminator-bound factor was detected in the affinity purified TFIIB preparation in the first
proteomic analysis carried out by Gavin et al., (97). However, in the second analysis,
poly(A)-binding protein (Pab1) which interacts with the poly(A) tail of mRNA was
identified as the only 3’ end processing factor interacting with TFIIB (96). The study
carried out by Krogan et al., found RNAP II subunits and two terminator-bound factors,
CPF subunit Fip1 and Pab1 interacting factor Pan2, co-purifying with TFIIB (166). The
absolute requirement of TFIIB in gene looping, crosslinking of TFIIB to both the
promoter and the terminator regions of a looped gene and its functional interaction with
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several 3’ end processing/termination factors including CF1 subunit Rna15 (83, 270)
suggested that a complex of TFIIB and termination factors exist in the cell.
We therefore investigated if TFIIB forms a macromolecular complex with CF1
subunits and Pap1 in yeast cells. Our experimental approach involved affinity
purification of TFIIB followed by detection of CF1 subunits and Pap1 in the purified
preparation by Western blot. To perform affinity purification of TFIIB, a triple
hemagglutinin (3XHA) tag was inserted at the carboxy-terminus of TFIIB. Insertion of
HA-tag did not interfere with the biological activity of TFIIB as both the transcription and
gene looping of MET16 and INO1 remained unaffected in the tagged strain (data not
presented). Additionally, a Myc-tag was integrated at the carboxy-terminus of each of
the five subunits of CF1 complex and Pap1 for their detection by Western blot. Thus, six
strains were constructed each carrying HA-tagged TFIIB and Myc-tagged version of one
of the subunits of CF1 complex and Pap1.
Cell lysates from each of the six strains described above were purified over antiHA-agarose beads. Proteins bound to the beads were eluted with HA oligopeptides.
Western blot analysis of eluates revealed the presence of Rna14 (Fig. 18, lane 3),
Rna15 (Fig. 18, lane 4), Pcf11 (Fig. 18, lane 5), Hrp1 (Fig. 18, lane 6), Clp1 (Fig. 18,
lane 7) and Pap1 (Fig. 18, lane 8) in the affinity purified TFIIB preparation. As a control,
purification was performed from a strain carrying untagged TFIIB. No signal for Rna14,
Rna15, Pcf11, Clp1, Hrp1 and Pap1 was observed in the absence of HA-tagged TFIIB
(Fig. 19), thereby confirming that the observed signals were due to the association of
these factors with TFIIB. MNase digestion of cell lysate prior to affinity purification did
not disrupt the association of CF1 subunits and Pap1 with TFIIB (Fig. 20, lanes 3 - 8).
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These results indicate that the interaction of terminator-bound factors with TFIIB is not
mediated by DNA or RNA. To rule out the possibility that copurification of Myc-tagged
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CF1 subunits and Pap1 with TFIIB is not due to
the interaction of the Myc-tag with TFIIB, the
affinity purification was performed in a strain
without a Myc-tag on any of the CF1 subunits or
Pap1. Western blot analysis of affinity purified
TFIIB, in this case using antibodies specifically
directed against Pap1 and CF1 subunit Rna15,
revealed that the interaction of these factors with
TFIIB is not dependent on the Myc-tag (Fig. 21,
lane 1). The affinity purification of a holo-TFIIB
complex described above was performed at KCl
concentration of 150 mM. To check the stability of the complex, we repeated the
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purification at 500 mM KCl in the lysis buffer. High ionic strength did not affect the
association of TFIIB with CF1 subunits and Pap1 during affinity purification (Fig. 22).

II.3.4. HOLO-TFIIB COMPLEX DOES NOT CONTAIN GENERAL TRANSCRIPTION
FACTORS
TFIIB has been shown to interact, both genetically as well as physically, with
TBP and RNAP II (71). We therefore checked for the presence of these proteins in the
affinity purified TFIIB preparation using antibodies directed against TBP and Rpb1
subunit of polymerase. No signal for either TBP (Fig. 1B, lane 2) or Rpb1 (Fig. 1B, lane
4) was detected in the TFIIB preparation. We also did not find any evidence for the
presence of another general transcription factor TFIIH in the affinity purified TFIIB
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preparation. Western blot analysis using antibodies against TFIIH subunit Kin28
confirmed the absence of the factor in the TFIIB preparation (Fig. 1B, lane 6). These

results suggest that the holo-TFIIB complex does not contain the factors that transiently
interact with it during the transcription cycle.
II.3.5. HOLO-TFIIB COMPLEX IS NOT OBSERVED IN LOOPING DEFECTIVE CELLS
To determine the physiological significance of TFIIB-CF1-Pap1 complex in the
context of gene looping, affinity purification of TFIIB was performed in a looping
deficient mutant strain of TFIIB called sua7-1. Affinity purified TFIIB preparation from
sua7-1 cells was subjected to SDS-PAGE analysis followed by Western blotting using
antibodies against Pap1 and CF1 subunit Rna15. Our results show that neither Pap1
nor Rna15 were found associated with TFIIB in sua7-1 strain (Fig. 21, lane 2). Thus,
TFIIB association with the terminator-bound factors occurred in a looping-dependent
manner. These results argue in favor of a TFIIB-CF1-Pap1 complex playing a crucial
role in loop formation.
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II.3.6. GLYCEROL GRADIENT ANALYSIS OF HOLO-TFIIB COMPLEX
To further confirm that a holo-TFIIB complex exists in yeast cells, affinity purified
TFIIB was subjected to sedimentation analysis on a linear 5-30% (v/v) glycerol gradient
in the presence of 150 mM KCl. Western blot analysis revealed that TFIIB fractionated
as a single peak spanning fractions 12 to 19 (Fig. 24). Pap1, as well as CF1 subunits:
Rna14, Rna15, Pcf11, Hrp1, and Clp1, cosedimented with TFIIB (Fig. 24). The peak of

CF1 subunits and Pap1 coincided with the TFIIB peak in fraction number 16 (Fig. 24).
To conclusively prove that TFIIB cosedimenting with CF1 subunits and Pap1 is not free
TFIIB, but TFIIB in a complex with 3’ end processing/termination factors, it was
important to determine the sedimentation behavior of free TFIIB. For this, we purified
recombinant TFIIB from bacteria and carried out sedimentation analysis under identical
conditions. Recombinant TFIIB sedimented in fractions 19 to 22 with the peak centered
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on fraction number 20 (Fig. 25). These results suggest that almost all TFIIB in the
affinity purified preparation is in complex with 3’ end processing/termination factors.
However, when sedimentation analysis of affinity purified TFIIB was carried out in
the gradient made in 500 mM KCl, TFIIB was separated from CF1 complex and

sedimented at a lower rate in fractions 18 to 22 with the peak in fraction number 20 (Fig.
25). To further corroborate the position of free TFIIB in the glycerol gradient,
sedimentation analysis of affinity purified TFIIB was also performed in a gradient which
contained 0.1% SDS. TFIIB and two subunits of CF1 (Rna14 and Rna15) were all found
in higher peak fractions near 19-20 (Fig. 26). These results correlate with the position of
free TFIIB based on the recombinant TFIIB peak centered on fraction 20. Thus, holoTFIIB complex is not stable upon prolonged exposure to high salt in a centrifugal field,
though it is able to withstand high ionic strength for a short period of time during affinity
purification.
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We then compared the sedimentation profiles of the holo-TFIIB complex with the
sedimentation profiles of RNAP II, TFIID and TFIIH complexes. The affinity purified

TFIIB, RNAP II, TFIID and TFIIH were subjected to sedimentation analysis under
identical conditions (Fig. 27). The presence of RNAP II, TFIID and TFIIH in the gradient
fractions was detected by Western blot analysis using antibodies against the Rpb1, TBP
and Kin28 subunits of RNAP II, TFIID and TFIIH respectively. RNAP II sedimented in
fractions 3 to 8 with the peak in fraction number 6 (Fig. 27). TFIID, which has a
molecular weight of about 750 kDa (23), sedimented in fractions 7 to 15 with the peak in
fraction number 11 (Fig. 27), while TFIIH with an approximate molecular weight of 500
kDa (80) sedimented in fractions 13 to 20 (Fig. 27). Thus, the sedimentation coefficient
of the holo-TFIIB complex is intermediate between that of the TFIID and TFIIH
complexes. We also looked for the presence of TFIIB in the gradient purified TFIID and
TFIIH preparations. No signal for TFIIB was detected in the TFIID, TFIIH or RNAP II
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glycerol gradient fractions (Fig. 27). This corroborated our earlier results that TFIIB is
not in a complex with general transcription factors.

II.3.7. SIZING COLUMN CHROMATOGRAPHY OF THE HOLO-TFIIB COMPLEX
Sedimentation analysis cannot provide accurate information about the size of
the complex because it measures the relative buoyancy in the gradient. In order to find
out the size of the holo-TFIIB complex, size exclusion chromatography was performed
using the HA-affinity purified TFIIB preparation on a superdex-200 column. The column
was calibrated with known sizing column markers. Elution profiles for each size marker
ranging in size from 669 kDa (Thyroglobin) to 158 kDa (Aldolase) was monitored for UV
absorbance and plotted (Fig 28). The superdex-200 column can accurately determine
the molecular sizes above 660 kDa. The elution profile of the affinity-purified TFIIB was
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monitored by UV as well as western blotting to confirm the presence of TFIIB with CF1
subunits indicating the holo-TFIIB complex was still intact after sizing column

chromatography (Fig 29). The peak fraction centered around an elution volume of 45
ml, which was near the 2 MDa blue dextran elution volume, indicating that the holo-

TFIIB complex is less than 2 MDa (Fig 30). However, we could not accurately determine
the size of holo-TFIIB complex from this column.
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II.3.8. TFIIB AFFINITY PURIFICATION SPECIFICALLY ENRICHES FOR TFIIB IN A
HOLO-TFIIB COMPLEX
Interestingly, there was no detectable signal for free TFIIB in either the glycerol
gradient or the sizing column fractions. One possibility is that most of the TFIIB inside
the cell is present in the holo-TFIIB complex. In order to address this issue, size
exclusion chromatography was performed using a whole cell extract prepared from a
strain that harbored the HA-tagged TFIIB. The purified fractions were then examined by
Western blotting for TFIIB. A similar peak for the holo-TFIIB complex was observed
around the elution volume of 45 ml along with three additional peaks near elution
volumes of 52, 59 and 68 ml (Fig 31). A reasonable estimate based on the blotting
intensities, would be that approximately 25-30% of the TFIIB in the cell forms a holo-
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TFIIB complex. One possible explanation for this selective enrichment during affinity

purification could be due to the two different conformations of TFIIB. In the closed
conformation, the N terminus and C terminus interact in a manner similar to a closed
wallet which could obfuscate the HA tag on the C-terminus. In order for TFIIB to interact
with activators and RNAP II, it switches to an open conformation where the N- and Cterminus are separated and free to physically interact with other proteins. TAP analysis
of TFIIB were also attempted in an effort to increase the yield over the oligopeptide
elutions. However, the addition of a TAP-tag to the C-terminal of TFIIB disrupted its
physical interaction with the CF1 subunits, and this strategy wasn’t pursued further.
II.3.9. KINETICS OF ACTIVATED TRANSCRIPTION IS COMPROMISED IN THE
ABSENCE OF GENE LOOPING
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We have earlier demonstrated that gene looping is conferred by the activatordependent interaction of the promoter-bound proteins with the terminator-bound factors
(83). Here we provide evidence for the existence of a complex of promoter-bound TFIIB
with the terminator-associated factors in yeast cells. This complex could be the
molecular basis of gene looping as it exists only in the looping competent strains, but
not in the looping defective strain. Gene looping has been proposed to enhance
transcription efficiency of a gene by coupling termination to reinitiation (235).
In such a scenario, efficiency of transcription is expected to decrease in the
absence of gene looping. We therefore compared kinetics of activated transcription of
MET16 and INO1 in wild type cells that harbor holo-TFIIB complex and in the looping
defective sua7-1 strain. Our results suggest that although both MET16 and INO1
exhibited induced transcription in sua7-1 strain, activated transcription exhibited a
kinetic lag in the looping defective strain (Fig. 32). The level of MET16 RNA in sua7-1
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cells was about 1.5 times less than in isogenic wild type strain following 90 min after
transfer of cells to inducing conditions (Fig. 32, lanes 3 and 6; Fig. 7C). Similarly, INO1
RNA level in sua7-1 cells was approximately 2.5 times less than in wild type cells at 120
min after induction of transcription (Fig. 32, lanes 3 and 6; Fig. 7F). A possible
interpretation of these results is that a looped conformation helps a gene to achieve
higher transcription efficiency within a short period of time following exposure of the
cells to induction signal.
II.4. DISCUSSION
In this study, we have analyzed gene looping during transcriptional activation of
protein encoding genes in budding yeast. Our results show that gene specific activators
physically interact with TFIIB in a transcription dependent manner. An activator may
function in association with TFIIB to keep a gene in the activated state through multiple
rounds of transcription by facilitating reinitiation through gene looping. TFIIB plays a
crucial role in gene looping. It has been proposed that the presence of TFIIB at the
distal ends of a gene and a simultaneous absence of TBP from the terminator region
are strong indicators of gene looping (83, 270). Our results with MET16 and INO1
corroborate this view. The first round of transcription requires the recruitment of all
general transcription factors and RNAP II on the promoter to form a PIC. Following
initiation of transcription, most of the general transcription factors are left behind on the
promoter in the form of a scaffold (325). During scaffold-based reinitiation, very few
components have to be recruited back to the promoter to form a preinitiation complex.
Reinitiation is therefore faster than initiation at least under in vitro conditions (143). If
RNAP II is transferred directly from the terminator to the scaffold, the rate of reinitiation
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is expected to be augmented even further (74). A gene looping assisted transfer of
polymerase from the terminator to the promoter, with a concomitant increase in
transcription efficiency, has been demonstrated during mitochondrial transcription (208).
Here we demonstrate that there is a kinetic lag in the looping defective TFIIB mutant,
which strongly suggests that RNAP II transfer from the terminator may be leading to
higher rates of reinitiation. Other work from our lab, which further corroborates this
hypothesis, has shown that in the termination defective mutants, gene looping is
abrogated and results in a 2 fold decrease of RNAP II recruitment on the promoter (6).
The localization of TFIIB on the terminator during active transcription and its
genetic interaction with Ssu72 indicate that TFIIB could physically interact with the
termination factors to mediate the formation of a gene looping complex. The results
presented here show that TFIIB associates with the CF1 3’ end processing complex and
Pap1 in yeast cells. We provide several lines of evidence in support of the existence of
a complex of TFIIB and termination factors. First, cross-linking of TFIIB to the 3’ end of
the gene, which is essential for loop formation, was abolished in looping-defective
temperature-sensitive mutants of Pap1 and the CF1 subunits Rna14 and Pcf11 at nonpermissive temperatures. Second, affinity purification of HA-tagged TFIIB yielded a
complex composed of Pap1 as well as CF1 subunits Rna14, Rna15, Pcf11, Clp1, and
Hrp1. Third, a holo-TFIIB complex is devoid of known TFIIB interacting proteins such as
RNAP II and TFIID. Thus, a TFIIB complex is not formed by transiently interacting
proteins. Fourth, a glycerol gradient sedimentation profile of affinity-purified TFIIB
showed a TFIIB peak cosedimenting with CF1 subunits and Pap1. Fifth, the
sedimentation rate of affinity purified TFIIB is more than that of free TFIIB, thereby
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suggesting that it is in a complex. These results provide strong support in favor of the
existence of a macromolecular complex composed of TFIIB and 3’ end processing
factors in yeast cells (Figure 33).
Our results indicate that the association of TFIIB with Pap1 and the CF1 complex

occurs only when the conditions are favorable for gene looping. First, Pap1 and CF1
subunit, Rna15, associate with TFIIB in a looping-competent strain. No such association
was observed in looping-deficient sua7-1 strain. Second, other work from our lab
demonstrated CF1 subunits and Pap1 were found localized to the 5’ end of a gene only
when it was in a looped conformation (212). These results suggest that a complex of
TFIIB, Pap1, and CF1 is formed at the promoter-terminator junction to facilitate loop
formation.
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We expected at least two populations of TFIIB in a cell: 1) free TFIIB that is not
engaged in transcription; 2) TFIIB in association with the terminator-bound factors on
genes that are in looped configuration. Contrary to our expectation, we did not find any
low sedimentation coefficient peak of free TFIIB in the glycerol gradient nor was there
any indication of free TFIIB in the fractions collected from the sizing column. One
possible reason for this could be that our affinity purification step is selectively purifying
the holo-TFIIB complex. Following the elution of TFIIB from affinity beads using
oligopeptides, there was still a substantial amount of TFIIB bound to the beads that
could be eluted with 0.5% SDS (data not presented). This tightly bound TFIIB could be
free TFIIB that was not be eluted with the anti-HA oligopeptides. Accordingly, we
demonstrated the presence of free TFIIB when the cell lysate was directly fractionated
on the sizing column. The earlier attempt to purify native TFIIB from yeast did not
observe a holo-TFIIB complex (288). A possible explanation for this is that the holoTFIIB complex is not stable upon prolonged exposure to high ionic strength. When we
performed sedimentation analysis of affinity-purified TFIIB at 500 mM KCl, TFIIB
dissociated from the complex and sedimented at the position of free TFIIB. During the
purification of native TFIIB from budding yeast by Tschochner et al. (288), at several
steps in the purification protocol, ionic strength equivalent to or higher than 500 mM
potassium acetate was used. This may have resulted in separation of TFIIB from the
termination factors, and consequently, a holo-TFIIB complex was not observed. The
holo-TFIIB complex may also include factors other than CF1 subunits and Pap1. It is
likely that some components of CPF complex are present in the TFIIB macromolecular
assembly. Ssu72, which is a subunit of CPF complex, exhibits a genetic as well as a
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physical interaction with TFIIB, and is a strong constituent candidate of the TFIIB
complex (72, 125, 278, 317). The presence of Pab1, Pab1-binding protein Pan1, and
CPF subunit Fip1 in the tandem affinity-purified preparation of TFIIB makes them likely
components of the TFIIB complex as well. Also, the presence of some promoter-bound
factors in the TFIIB preparation cannot be ruled out.
A similar interaction of mammalian TFIIB with CPSF and CstF, which are
homologues of yeast CPF and CF1 cleavage and polyadenylation complexes, has also
been observed (296). TFIIB exhibited a physical interaction with CstF-64 and mSsu72
subunits of CstF and CPSF complexes, respectively. CstF-64 and mSsu72 were also
found cross-linked to the distal ends of a gene in a manner analogous to their yeast
counterparts. Furthermore, TFIIB phosphorylation was required for the recruitment of
CstF-64 and mSsu72 to the promoter region of a gene. Whether association of TFIIB
with CstF and CPSF complexes facilitates juxtaposition of the promoter and terminator
regions to form a gene loop in higher eukaryotes remains to be elucidated.
TFIIB is absolutely required for initiation of transcription and its interactions with
promoter-bound factors are well established. The essential role of TFIIB in gene
looping, its interaction with the terminator-bound factors, and the kinetic delay in
induced transcription suggests a novel role of TFIIB in looping-mediated transcriptional
regulation. A genomewide search found TFIIB occupying both the promoter and the
terminator regions of at least 120 genes in yeast (209). These results suggest that gene
looping could be a general feature of transcriptionally activated genes in budding yeast.
The role of gene looping may not be restricted to activation of transcription. We expect
promoter-terminator interaction to have a wider implication in eukaryotic transcription. It
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has been recently demonstrated that gene looping juxtaposes an inhibitory regulatory
element located at the 3’ end of BRCA1 gene near its promoter region, leading to
transcriptional repression of the gene in breast tumor cell lines (282). In this case, gene
looping represses rather than activates transcription. In human B- and T-lymphocytes,
interaction of the promoter with the terminator region of CD68 had an effect on the
splicing of its primary transcript (234). A role for gene looping in preventing transcription
interference has also been proposed in budding yeast, where gene density is high with
little intervening space between neighboring genes (235). Gene looping may have
different consequences, but it is certainly emerging as a general, possibly ubiquitous,
transcription regulatory mechanism among eukaryotes.
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CHAPTER III
A NOVEL ROLE OF TFIIH KINASE, KIN28, IN TERMINATION OF TRANSCRIPTION
IN BUDDING YEAST
III.1. ABSTRACT
TFIIH is a general transcription factor with two different enzymatic activities, a
kinase and a helicase activity. The kinase activity resides in the Kin28 subunit of TFIIH.
There are conflicting reports regarding the role of Kin28 kinase in transcription cycle.
Using an analog-sensitive mutant of Kin28, here we show that the Kin28 kinase is
required for optimal transcription of both inducible and non-inducible genes in budding
yeast. Transcription run-on analysis confirmed that the Kin28 kinase dependent
enhancement of transcript level was the consequence of a direct affect of the kinase on
transcription rather than on RNA stability. More importantly, RNAP II reads through the
termination signal into the downstream regions of genes during kinase inhibition,
thereby indicating a termination defect. The recruitment of Rna15 and Ssu72 subunits of
CF1 and CPF termination complexes respectively near the 3′ end of genes was
adversely affected in the kinase mutant. Both Rna15 and Ssu72 coimmunoprecipitated
with Kin28 thereby suggesting a physical interaction of the kinase with the CPF and
CF1 termination complexes. ChIP analysis revealed Kin28 crosslinking to both the 5′
and the 3′ ends of transcriptionally active genes. The localization of Kin28 towards the 3′
end of genes and its interaction with Rna15 and Ssu72, however, was compromised in
the kinase-defective mutant. These results strongly suggest a novel role of Kin28 kinase
in termination of transcription. CCC analysis revealed that gene looping, which is the
physical interaction of the promoter and terminator regions of a gene during
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transcription, was severely compromised in the Kin28 kinase mutant. We propose that
Kin28 kinase dependent gene looping could be playing a crucial role in TFIIH-mediated
termination of transcription in budding yeast.
III.2. INTRODUCTION
Although TFIIH is a general transcription factor, its fundamental role in cell is not
limited to transcription. It has additional cellular functions in DNA repair, and cell cycle
regulation (80). Mutations in TFIIH subunits Ssl2 and Rad3 (XPB and XPD in humans)
adversely affect both transcription and DNA repair, and cause autosomal recessive
disorders; xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy (61).
These diseases are characterized by predisposition of the affected individuals to
cancer, ageing, developmental and neurological defects. The multiplicity of functions
has made TFIIH the focus of intense investigation.
TFIIH is a multisubunit factor with a molecular weight of more than 500 kDa. It
has been remarkably conserved during evolution, and has essentially the same subunit
structure in yeast and higher eukaryotes (20, 99). The holo-TFIIH complex is composed
of 11 subunits organized into two subcomplexes (Fig. 13) (224). The subunit
organization of TFIIH reflects its multiplicity of functions in the cell. The core
subcomplex comprising of Tfb1, Tfb2, Ssl1, Tfb4, Tfb5 and Rad3 in budding yeast, is
required for transcription as well as DNA repair (99). Another subunit Ssl2 is loosely
associated with the core subcomplex, and is indispensable for both transcription and
repair of damaged DNA (224). Recently, an additional subunit Tfb6 was identified that
facilitates dissociation of Ssl2 from the core subcomplex following the initiation of
transcription (224). The kinase subcomplex, also known as TFIIK, is composed of Tfb3,
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the cyclin Ccl1, and the cyclin-dependent kinase Kin28 (93). TFIIK phosphorylates the
carboxy-terminal domain (CTD) of RNAP II at serine-5 and serine-7 residues, and is
required for transcription as well as cell cycle control (3, 156). The structural analysis
revealed TFIIH as an open ring like structure with a hole in the center that contacts
DNA. The three-dimensional reconstruction of TFIIH on the basis of electron
microscopy and X-ray diffraction studies places critical catalytic subunits of TFIIH in
proximity of their target substrates (46). Ssl2 helicase crosslinked to DNA about 30 bp
downstream of the transcription start site, while Kin28 kinase was found positioned near
its CTD substrate. Rad3 helicase was localized near the DNA upstream of the
transcription initiation bubble (126).
TFIIH is the only GTF with two distinct enzymatic activities: the DNA-dependent
helicase activity and the cyclin-dependent kinase activity (80, 99). The helicase activity
resides in two subunits, Ssl2 and Rad3, while Kin28 is the cyclin-dependent kinase.
Ssl2 contacts template downstream of the transcription start site, and act as a molecular
wrench to unwind DNA beyond the transcription bubble (126). This causes collapse of
the initiation bubble, and facilitates release of the polymerase from the promoter for
elongation, a step often referred to as the promoter clearance (199). Kin28 kinase
phosphorylates serine-5 of CTD in the initiation complex (35, 159). The CTD-serine-5
phosphorylation is believed to disrupt the interaction of the polymerase with the
components of the initiation complex, thereby helping further in the promoter clearance
(4, 196, 279, 308). The serine-5 phosphorylation also facilitates recruitment of the
capping enzyme for 5ʹ end processing of nascent mRNA (93, 251). Kin28 was recently
found to additionaly phosphorylates serine-7 of CTD (3, 79, 156).
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There are contradictory reports regarding the role of TFIIH kinase, Kin28, in
transcription by RNAP II (20, 136, 147, 196). Transcription starts with the formation of
PIC at the promoter. During PIC assembly, recruitment of GTFs and polymerase takes
place in an ordered fashion, starting with TFIID followed by TFIIA, TFIIB, RNAP II-TFIIF,
TFIIE and TFIIH in that order (Fig. 3) (111, 126, 248, 269, 285). RNAP II is recruited in a
completely dephosphorylated form. The phosphorylation of CTD is not required either
for PIC assembly or initiation of transcription (5, 35). The polymerase initiates
transcription while sitting on the promoter, and still in contact with the general
transcription factors (36, 164). The phosphorylation of serine-5 of CTD takes place
immediately after initiation (159). The role of serine-5 phosphorylation has been found
crucial for promoter clearance, which is the release of polymerase from the initiation
complex for elongation (35, 142, 202, 308). The significance of serine-5 phosphorylation
in the recruitment of capping enzyme for 5ʹ end processing of mRNA has been
unequivocally demonstrated (53, 89, 211, 251). Our initial understanding of the function
of TFIIH kinase under physiological conditions has come from studies with the
temperature-sensitive mutants of Kin28 in budding yeast. Kin28 is an essential gene in
yeast, as the cells lacking Kin28 are not viable. The shifting of Kin28 mutants to the
elevated temperature adversely affected the recruitment of TFIIH complex at the
promoter resulting in a dramatic decrease in the CTD-serine-5 phosphorylation, and a
concomitant decrease in the level of steady state mRNA level in the cells (134, 196).
The temperature-sensitive mutation has been found to affect the catalytic activity of
Kin28 kinase as well as its interaction with other subunits of TFIIH (144, 151). To
determine the specific role of Kin28 kinase in transcription by RNAP II, the ATP-binding
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pocket of the enzyme was engineered to make it respond to a specific inhibitor NA-PP1,
which is an analog of ATP. In the presence of NA-PP1, the kinase activity of analogsensitive Kin28 mutant (Kin28-as) is almost completely inhibited without affecting its
interaction with the subunits of TFIIH complex (196). The studies using Kin28-as mutant
revealed that the kinase activity is not required for recruitment of TFIIH at the promoter
region. The startling finding was that Kin28 kinase is not essential for transcription (136,
147, 308). A drastic decline in global transcript level in the absence of Kin28 kinase
activity, however, was observed (136). This decrease in mRNA level in the Kin28-as
mutant was attributed to the effect of serine-5 phosphorylation on capping of mRNA at
the 5′ end rather than a direct role of Kin28 kinase in transcription (136). This view has
been challenged by recent studies, which have reaffirmed the role of Kin28 kinase in
promoter clearance (142, 308). These studies also implicated serine-5 phosphorylation
in release of Mediator complex from the promoter-proximal region following initiation of
transcription. Thus, the role of Kin28 kinase in transcription cycle remains elusive.
To investigate the precise role of Kin28 kinase in transcription by RNAP II, we
examined the transcription of a number of inducible and constitutively expressed genes
in Kin28-as mutant in the presence and absence of NA-PP1. Our results suggest that
Kin28 kinase is not the absolute requirement for transcription, but is necessary for
optimal transcription of both inducible and non-inducible genes. The kinase crosslinked
to both the 5′ and 3′ ends of transcriptionally engaged genes. In the presence of analog
NA-PP1, Kin28-as localization to the 5′ end of genes remained unaffected, but
crosslinking to the 3′ end exhibited a dramatic decline. The delocalization of Kin28 from
the 3′ end coincided with the polymerase reading through the termination signal.
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Furthermore, gene looping was severely compromised in the kinase defective mutant.
These results suggest a novel role of Kin28 kinase in termination of transcription,
possibly through gene looping.
III.3. RESULTS
III.3.1. KIN28 KINASE IS REQUIRED FOR OPTIMAL TRANSCRIPTION OF BOTH
INDUCIBLE AND CONSTITUTIVELY EXPRESSED GENES
The gene coding for Kin28 is essential for survival of yeast cells. Apart from the
CTD-kinase activity, Kin28 is also essential for the recruitment of the holo-TFIIH
complex at the promoter region of transcriptionally active genes. The CTD-kinase
activity of Kin28 is neither essential for transcription nor for the survival of yeast cells
(147). The growth of cells, however, is severely inhibited in the kinase-defective mutant,
thereby suggesting that either Kin28 kinase is affecting the transcription cycle in a
subtle way, or it is playing a role in a yet unknown aspect of cellular dynamic (Fig. 34)
(147). To further probe the function of Kin28 kinase in transcription by RNAP II, we used

an analog-sensitive strain of Kin28 called Kin28-as that has been used previously (196).
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The Kin28-as strain is able to accommodate the analog NA-PP1. The analog is a highly
specific competitive inhibitor of Kin28 kinase. In the presence of 5-10 µM NA-PP1 in the
growth medium, the CTD kinase activity of Kin28-as mutant is almost completely
inhibited within 60 minutes.
To investigate the precise function of Kin28 kinase in transcription cycle, we
examined transcription of both inducible and constitutively expressed genes in Kin28-as
mutant in the presence and absence of 7 µM NA-PP1 in the growth medium. Equal
numbers of cells were harvested at 0, 30, 60 and 90 minutes following addition of NAPP1 to the cultures in mid-log phase. Total RNA was isolated and steady state level of
mRNA was determined by RT-PCR approach. We first checked the effect of Kin28
kinase on five inducible genes; HXT1, MET16, CHA1, GAL10 and INO1. Our results

show that a defect in Kin28 kinase affected the mRNA level of different inducible genes
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to different extent. The transcript level of HXT1, MET16 and CHA1 decreased by about
2-3 fold, of GAL10 by 5 fold, and of INO1 by about 10 fold in the Kin28-as strain in the
presence of NA-PP1 (Fig. 35). No such decrease in RNA level was observed in the
isogenic wild type strain in the presence of NA-PP1 or in the Kin28-as strain in the
absence of NA-PP1 (Fig. 35). Next, we checked the role of Kin28 kinase on
transcription of five constitutively expressed genes; ACT1, ASC1, MSN5, SPC2 and
CMP2. A similar decline in mRNA level was observed for all five non-inducible genes
tested in our experiments. The steady state amount of transcripts of ACT1, ASC1,
MSN5, SPC2 and CMP2 registered a more or less uniform moderate decline of 2-3
folds in the analog-sensitive mutant in the presence of NA-PP1 (Fig. 36).

The Kin28 kinase activity is essential for capping of mRNA at the 5′ end of genes.
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Since capping of mRNA has been shown to affect the stability of mRNA, it was possible
that the observed decrease in mRNA level of genes in the absence of kinase activity
was not due to the effect of kinase on transcription, but on the stability of transcripts. To
clarify the issue, we checked the nascent transcription of two inducible genes CHA1 and
HXT1, as well as two constitutively expressed genes ACT1 and ASC1, by strandspecific transcription run-on (TRO) approach. TRO assay is a better indicator of
transcriptional activity of a gene than RNAP II density ChIP as it measures the position
of transcriptionally active polymerase on a gene (Fig. 37). The Kin28-as cells were
grown to the mid-log phase, and transcription was induced in the presence and absence
of NA-PP1 as described previously. The strand- specific TRO analysis was carried out
using Br-dUTP as described in Al Husini et al., (2013). The results show that the
nascent transcription of CHA1 decreased by about 8 fold and of HXT1 by more than 20
fold in the presence of NA-PP1 (Fig. 38). The nascent transcription of two constitutively

expressed genes ACT1 and ASC1 also registered a steady 1.5-2 fold decline in the
absence of Kin28 kinase activity (Fig. 38).
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Thus, the decrease in the steady state mRNA level of both inducible and non-inducible
genes observed by RT-PCR analysis was the consequence of a direct effect of kinase
on transcription of genes. An additional indirect role of Kin28 kinase on stability of the
transcripts has been shown, and cannot be ruled out here.
III.3.2. KIN28 KINASE IS REQUIRED FOR TERMINATION OF TRANSCRIPTION
The strand-specific TRO analysis of genes in the Kin28-as strain revealed a
startling rather unexpected role of Kin28 in RNAP II transcription cycle. In all four genes
that we tested, polymerase read through the termination signal in the absence of Kin28
kinase activity thereby signifying a defect in termination of transcription of these genes
(Fig. 38). The TRO assay detects the presence of transcriptionally active RNAP II on a
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gene. When termination is efficient, the active polymerase is restricted between the
promoter and terminator regions of a gene. In the termination-defective mutants,
however, polymerase reads through the terminator signal into the downstream region of
the gene. TRO analysis revealed a weak polymerase signal in the downstream regions
2 and 3 of CHA1, HXT1, ACT1 and ASC1 in the mutant in the absence of NA-PP1 (Fig.
38). In the presence of NA-PP1, however, TRO signal in the downstream regions 2 and
3 of all four genes increased by about 2-10 fold (Fig. 38). Thus, RNAP II was not able to
read

the termination signal of CHA1, HXT1, ACT1 and ASC1 efficiently under kinasedefective condition and continued transcribing the downstream regions. These results
suggest a role for Kin28 kinase in termination of transcription. The RNAP II density ChIP
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assay corroborated readthrough of polymerase beyond the termination signal under
kinase defective condition (Fig. 39).
To further probe the role of Kin28 kinase in termination, we checked the
recruitment of CF1 and CPF termination complexes, which are required for both 3’ end
processing/termination near the terminator region of genes in the kinase defective
mutant.

We expected that if Kin28 kinase activity is required for termination of

transcription, the recruitment of either CF1 or CPF or both complexes will be adversely
affected under kinase defective condition. Both CF1 and CPF complexes are composed

of multiple subunits (205, 249). We used a ChIP approach to monitor the recruitment of
CF1 complex towards the 3' end of CHA1, HXT1, ACT1 and ASC1 genes using its
Rna15 subunit, while SSu72 subunit was used to detect the recruitment of CPF
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complex in the mutant strain. ChIP analysis revealed that both Rna15 and Ssu72
occupied the terminator region of all four genes in the mutant in the absence of NA-PP1
(Figs. 40 and 41). In the presence of NAPP1, however, crosslinking of Rna15 to the 3'

end decreased by about 50-80% (Fig. 40), while that of Ssu72 declined by more than
75% (Fig. 41). Thus, the recruitment of both the CF1 and the CPF complexes towards
the terminator region of CHA1, HXT1, ACT1 and ASC1 was compromised under the
condition of deficient Kin28 kinase activity. Taken together these results strongly
suggest a novel role for Kin28 kinase in termination of transcription for at least a subset
of genes in budding yeast.
III.3.3. MECHANISM OF TERMINATION OF TRANSCRIPTION BY KIN28
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The termination of transcription by RNAP II is dependent on CTD-serine2
phosphorylation and requires CF1 and CPF 3′ end processing/termination complexes in
yeast (2, 17, 29, 35, 72, 189, 249). The serine-2 phosphorylation starts during early
elongation, continues throughout the coding region and drops sharply after the poly(A)
site (78, 159). The phosphorylation of CTD at serine-2 facilitates recruitment of CF1 and
CPF complexes near the 3′ end of a gene, which then brings about termination of
transcription (131, 249). So far, there is no report of CTD-serine-5 or CTD-serine-7
playing any role in termination of transcription in yeast or higher eukaryotes.
The Kin28 kinase may affect termination indirectly by influencing CTD

phosphorylation towards the 3' end of genes, or directly by interacting with the
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termination factors and facilitating their recruitment near the terminator region. To test
the first scenario, we checked CTD phosphorylation status in different regions of CHA1
and ACT1 in the analog-sensitive Kin28 mutant in the presence and absence of NAPP1. ChIP analysis revealed no change in the CTD-serine2 phosphorylation pattern
near the 3′ end of any of the two genes in the presence of NA-PP1 (Fig. 42 and 43). We
then examined the phosphorylation status of CTD-serine-5 and CTD-serine-7 near the
3′ end of CHA1 and ACT1 in the mutant strain. Although phosphorylation of serine5

near the promoter-proximal region is well established, there are conflicting reports
regarding its phosphorylation near the 3′ end of genes (78, 286). A few recent studies
demonstrated phosphorylation of serine-5 at the 3′ end in a subset of yeast genes (78,
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286). Our results are in agreement with these reports. We found elevated levels of
serine5 phosphorylation at the 3′ end of both CHA1 and ACT1 (Fig. 42 and 43). A
similar elevated level of serine-7 phosphorylation was observed near the terminator
region of both genes (Figs. 42 and 43). In the presence of NA-PP1, however, a 2-4 fold
decrease in phosphorylation of both serine-5 as well as serine-7 was observed for two
genes in the analog-sensitive mutant (Fig. 42 and 43). These results ruled out the
possibility of Kin28 kinase playing an indirect role in termination of transcription by
affecting CTD-serine-2 phosphorylation near the 3′ end of genes. Since inactivation of
Kin28 kinase resulted in lowering of both CTD-serine-5 and serine-7 phosphorylation
near the 3′ end of genes (Fig. 42 and 43), the possibility of serine-5 and serine-7 playing
a role in termination of transcription cannot be ruled out.
III.3.4. KIN28 PHYSICAL INTERACTION WITH RNA15 AND SSU72 IS DEPENDANT
ON ITS KINASE ACTIVITY
To check the possibility of a direct role of Kin28 in termination of transcription, we
examined its interaction with the CF1 and CPF complexes using coimmunoprecipitation
approach. The strains were constructed with the TAP-tagged version of Kin28-as allele,
and either Myc-tagged Rna15 or Myc-tagged Ssu72. Kin28 was immunoprecipitated
using IgG-Sepharose beads, and the presence of either Rna15 or Ssu72 was detected
in the immunoprecipitated fraction in the presence and absence of NA-PP1. Our results
show that Kin28 interacts with both CF1 subunit Rna15 and CPF subunit Ssu72 in the
absence of NA-PP1 (Fig. 44). In the presence of NA-PP1, however, Kin28 interaction
with both RNA15 and Ssu72 was completely abolished (Fig. 44). These results show
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that Kin28 interacts with both the CF1 and CPF complexes, and this interaction is
completely dependent on its kinase activity. In order to rule out the possibility that this
interaction is DNA dependent, an identical co-immunoprecipitation was performed with
an additional MNase treatment prior to purification (Fig. 45). Whether Kin28-CF1 and
Kin28-CPF

interactions

are

facilitated by the Kin28-mediated
phosphorylation of CTD or that of a
subunit of CF1 or CPF complex
needs further investigation. The
possibility

of

Kin28

influencing

termination both indirectly by affecting the CTD phosphorylation in the terminator region,
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and directly by interacting with the termination factors near the 3′ of the gene also
cannot be ruled out.
III.3.5. TFIIH LOCALIZATION TO THE DISTAL ENDS OF GENES DURING
TRANSCRIPTION REQUIRES ITS KINASE ACTIVITY
The experiments described above firmly established the role of Kin28 kinase in
termination of transcription of at least a subset of yeast genes. In order to have an
insight into the role of Kin28 kinase in termination of transcription, we checked if Kin28
brings about termination by physically interacting with the 3′ end of genes and if the
kinase activity is required for this interaction. The chromatin immunoprecipitation (ChIP)
was performed in a strain bearing TAP-tagged version of Kin28-as allele. ChIP was
performed in cells growing in the presence and absence of NA-PP1. As expected, Kin28

was recruited towards the 5' end of CHA1, HXT1, ACT1 and ASC1 in the absence of
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NA-PP1 (Fig. 46). In the presence of NA-PP1, however, crosslinking of Kin28 to the
promoter region of both inducible and non-inducible genes registered a 50-80% decline
(Fig. 46). Interestingly, Kin28 was also found localized near the 3' end of all four genes
tested here (Fig. 46). A genomewide analysis has also found Kin28 crosslinked to the 3'
end of a number of transcriptionally active genes in yeast (248). It was, however, not
clear from this study if the recruitment of Kin28 near the terminator region required its
kinase activity. We therefore repeated the ChIP experiment in Kin28-as mutant in the
presence of inhibitory analog. Our results show that the crosslinking of Kin28 towards
the terminator region of both genes was significantly reduced in the absence of its

kinase activity (Fig. 46). The Kin28 ChIP signal at the 3' end of CHA1 and ACT1
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decreased by nearly 50%, while at HXT1 and ASC1 more than 75% decline was
observed under kinase-defective condition (Fig. 46).
In order to distinguish if Kin28 is being recruited as part of the TFIIK submodule
or the entire TFIIH, ChIP was performed in kinase sensitive strains harboring a Cterminal TAP-tagged Ssl2 or Tfb4. In both cases, the recruitment profile on the promoter
and terminator regions were very similar to that observed for Kin28 in the presence and
absence of the NA-PP1 inhibitor (Fig. 47). The overall conclusion of these results is that
TFIIH, and not just TFIIK, is recruited at the promoter as well as terminator regions of a
gene during transcription, and the kinase activity is required for the optimal recruitment
of TFIIH to a gene.
III.3.6. KIN28 KINASE IS REQUIRED FOR GENE LOOPING
We have earlier demonstrated the role of Mediator complex in transcription
termination (221). We showed that Mediator-facilitated termination of transcription was
dependent on the gene assuming a looped conformation. We therefore asked if Kin28
kinase-mediated termination of transcription is also dependent on gene looping. CCC
analysis of CHA1, HXT1, ACT1 and ASC1 was carried out in Kin28-as cells in the
presence and absence of kinase activity. We have previously used this approach to
demonstrate looping of genes in a transcription-dependent manner (83). In CCC assay,
the physical interaction of the promoter and terminator regions of a gene is converted
into a PCR product obtained using primers flanking the promoter (P1 primer) and the
terminator (T1) regions as shown in Fig. 10 (82). CCC analysis revealed that CHA1,
HXT1, ACT1 and ASC1 assume a looped gene conformation during transcription in wild
type cells as indicated by a strong P1T1 PCR signal for all four genes (Fig. 48). In the
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Kin28-as mutant also, a strong P1T1 looping signal was observed during induced

transcription of CHA1, HXT1, ACT1 and ASC1 in the absence of NA-PP1 (Fig. 48). In
the presence of NA-PP1, however, the looped gene architecture of all four genes was
almost completely abrogated as there was 3-40 folds decline in P1T1 PCR signal for
different genes (Fig. 48). Thus, the kinase activity of Kin28 is essential for gene looping.
Whether Kin28 kinase-mediated gene looping contributes to the termination of
transcription, however, needs further investigation.
III.4. DISCUSSION
Since its discovery, the function of CTD kinase activity of TFIIH in transcription
has been the focus of intense scrutiny. Using the analog-sensitive mutant of Kin28, it
has been demonstrated that Kin28 kinase is neither essential for transcription nor for
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survival of yeast cells (136, 147). These studies measured transcription in terms of
steady state mRNA level, which is dependent on transcription as well as RNA
degradation. The observed decrease in global transcript level in the absence of Kin28
kinase activity was attributed to its affect on RNA stability rather on transcription per se
(136). We therefore measured nascent transcription of selected genes in the presence
and absence of Kin28 kinase activity by a TRO assay. Our results suggest that Kin28
kinase is not an absolute requirement for transcription, but is required for optimal
transcription of genes. Kin28 kinase may not be essential for transcription of all proteincoding genes. The prevailing view is that the general transcription factors TFIID, TFIIB,
TFIIF, TFIIE and TFIIH are required for the transcription of a vast majority of RNAP IIdependent genes (201, 223, 292). This may not be entirely true. A recent study
revealed that the TFIIB is required for transcription of only a subset of genes in humans
(98). We propose that the Kin28 kinase activity of TFIIH may also not be necessary for
transcription of all RNAP II-transcribed genes. If the TFIIH-kinase is required for
transcription of a subset of non-essential genes, the cell may still be viable in the
absence of the kinase activity, but the cell fitness may be adversely affected. This may
explain why a defect in Kin28 kinase does not affect the cell viability and global poly(A)mRNA level appreciably, but is still necessary for normal growth of yeast cells.
The Kin28 kinase occupies both the 5′ and the 3′ end of genes. Most studies
have focused on the role of TFIIH kinase at the 5′ end of genes. We, however, were
curious regarding a possible function of Kin28 kinase at the 3′ end of genes. Here we
demonstrate a novel role of Kin28 kinase in termination of transcription. We provide
several lines of evidence in support of our claim. First, localization of Kin28 at the 3′ end
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of genes is dependent on the kinase activity of protein. Second, recruitment of CF1 and
CPF termination complexes towards the terminator end of gene is compromised in the
absence of kinase activity. Third, the interaction of Kin28 with the CF1 and CPF
complexes is almost completely abolished in the Kin28 kinase-defective mutant. Fourth,
RNAP II reads through the termination signal into the downstream region under the
kinase-defective condition. TFIIH is not the only general transcription factor that has
been implicated in termination of transcription. A similar termination function has been
found for TFIIB as well. Just like Kin28, TFIIB crosslinks to the 3′ end of genes and
facilitates recruitment of the termination factors there (212). The termination function of
TFIIB has been remarkably conserved during evolution, as it has been observed in a
wide range of organisms as yeast, mammals and flies (128, 222, 296). We recently
demonstrated the role of another initiation factor, Mediator complex, in the termination
of transcription (221, 222). The emerging view is that the initiation and termination
factors do not have exclusive roles in the initiation and termination steps of transcription
respectively. We have shown that at least some initiation factors participate in the
termination of transcription, while additionally, some termination factors function in the
initiation/reinitiation of transcription (6).
We have previously demonstrated that gene looping facilitates interaction of the
promoter-bound factors with the 3′ end of genes, and of terminator-bound factors with
the 5′ end of genes (6, 83, 212, 221). We hypothesize that it is gene looping that allows
a transcription factor to function at both the ends of a gene. The termination function of
TFIIB is completely dependent on its interaction with the 3′ end of a gene. We propose
that Kin28 crosslinking to the 3′ end of a gene, and its consequent role in termination of
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transcription is also dependent on gene looping. Accordingly, we show that there is no
gene looping in the Kin28 kinase defective mutant. These results suggest that the Kin28
kinase activity is essential for promoter-terminator interaction. Loss of gene looping in
Kin28-kinase deficient mutant coincides with the loss of Kin28 from the 3′ end of genes,
and a defect in termination of transcription. A role of gene looping in termination of
transcription by TFIIB has already been demonstrated. The possibility of Kin28-kinasemediated gene looping contributing to its termination function, therefore, cannot be ruled
out.
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CHAPTER IV
CONCLUSIONS
IV. 1. SUMMARY
The physical and genetic interactions of the promoter and terminator bound
factors were initially only a hint that the initation and termination steps in the
transcription cycle are intimately linked. The results presented here demonstrate that
initiation factors such as TFIIB and TFIIH are simultaneously present at both the
promoter and terminator regions of a gene during active transcription. Other work from
our lab has shown similar results with the ‘promoter bound’ Mediator complex and
‘terminator bound’ CF1 complex. Work using temperature sensitive mutants has
revealed that these reciprocal localizations at the distal ends of a gene depended on the
presence of functional complexes. The hypothesis that the physical contact of these
complexes is the molecular basis of gene looping is strongly supported by the isolation
of a holo-TFIIB gene looping complex containing CF1 subunits and the CPF subunit
Pap1. Perhaps the most suprising result was the failure to detect TFIIH (Kin28) as part
of the holo-TFIIB complex considering it also genetically interacts with Ssu72 and
localizes on the terminator. This might be explainable given that in vitro evidence shows
the release of TFIIB from the inititation scaffold that is left behind after the first round of
transcription, composed at least partially of TFIID, TFIIA, and TFIIH. In vivo, it appears
that TFIIB remains on the promoter, probably through gene looping interactions with the
termination factors. Although at this point, the involvement of other promoter bound
factors such as Mediator, in stabilizing TFIIB on the promoter, can not be ruled out.
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TFIIH localization on the terminator region was interesting with regard to gene
looping because of the kinase activity of subunit Kin28. Phosphorylation is perhaps the
most well investigated post translational modification which can dictate an ‘on’ or ‘off’
state for many proteins. While TFIIH wasn’t detected in the holo-TFIIB gene looping
complex, TFIIH could still be playing crucial roles in the formation of such a complex.
The results presented here clearly show a role for TFIIH in the termination process.
While in vitro studies have shown termination factor recruitment on a CTD peptide
phosphorylated at serine-2, it is unclear how stable these complexes are in vivo. The
CTD ChIP results hint that TFIIH could be indirectly affecting their stability based on
phosphorylation of the CTD at serine-7. In addition, TFIIH could be playing a more
direct role based on its physical interaction with termination factors and phosphorylating
them in order to function properly. Although it is not definitively proven, TFIIH appears to
be responsible for phosphorylating TFIIB at serine-65, which has been shown to be
required for the recruitment of termination factors to the promoter and terminator (296).
In addition, p53 has been shown to override a lack of TFIIB for the transcription of
damage response genes and also recruit termination factors in a manner similar to
TFIIB forming a gene loop (267). This indicates that there may be other mechanisms
which can result in the formation of gene loops, and perhaps the only requirement for
any promoter bound factor is that it also interacts with termination factors. This could
possibly be tested by simply fusing an activator protein with one of the termination
factors. Also, many viral activator proteins are thought to recruit TFIIB directly to
promoters without the formation of a usual PIC, driving a ‘short circuit’ to transcription
initiation and gene looping. Recently, it has been shown that in differentiated kidney

91

cells, TFIIB is not necessary for transcription of all genes as previously thought. It was
however, required for expression of the herpes simplex virus-1 (98). In the future, a
better understanding of how gene loops form could be important for disrupting viral
transcription.
IV. 2. FUTURE DIRECTIONS
My work presented here is far from a complete story, and seems to create more
questions than it has answered. The TFIIB work begs to ask at least a few questions
regarding the holo-TFIIB complex. How big is it really? What are all of the composing
factors? What is TFIIB interacting with directly where a single amino acid change
prevents the formation of a gene looping looping complex? Furthermore, while not
shown here, why does a C terminal TAP tag on TFIIB interfere with isolating a gene
looping complex, but doesn’t affect TFIIB localization on the terminator?
In order to determine how big it really is, a different column needs to be used.
Then, large amounts of the holo-TFIIB complex could be purified and concentrated
enough to get good mass spec data. The most interesting question is finding what
directly interacts with TFIIB near the region containing the E62K that is critical for gene
looping. I have begun the process of creating point mutants (2 so far) that are capable
of incorporating a photo-crosslinkable amino acid (Bpa) at the site. The factor(s?) could
then be discovered using a Western blot if they had an affinity tag. Otherwise, bands
could be cut out of the gel where a crosslinked TFIIB was present and then subjected to
mass spec to identify the interacting protein.
The work presented here on TFIIH opens up several lines of interesting research
in order to understand how TFIIH is affecting termination and gene looping. Is TFIIH
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phosphorylating termination factors directly? Is the kinase activity of TFIIH facilitating
the recruitment at the promoter and terminator through the CTD?It is also possible that
TFIIH could be working in a kinase cascade with other kinases involved in initiation and
termination.
While a few of the targets of Kin28 kinase are known, it is not known if any of the
termination factors are among them. If TFIIH is targeting termination factors this could
explain the lack of recruitment during kinase inhibition due to the inability of that factor
to stabilize the association of that termination complex. Alternatively, it could also be
due to the inability to phosphorylate other promoter bound factors perhaps acting in a
role similar to TFIIB, where TFIIB phosphorylation stabilizes CF1 recruitment by direct
interaction with Rna15 (296). TFIID and SAGA are both relatively large complexes (over
15 subunits) and a few Kin28 targets have been found within them. In order to
investigate this in an unbiased manner, inititiation and termination complexes would
need to be purified and subjected to 2-dimensional PAGE to compare the spots with/out
kinase inhibition. Those spots would then have to be analyzed with mass spec in order
to identify the target proteins. Furthermore, those factors identified would then need to
be mutated at the appropriate phosphorylation sites to ascertain if they are involved in
gene loop formation.
While genomewide studies have provided key insights into patterns of CTD
phosphorylation, recent studies indicate that creating an average pattern may not be
reflective for all genes (286). Understanding the exact nature of how CTD
phosphorylation patterns affect the stability and recruitment of the termination
machinery will require the creation of several specific CTD mutants where each

93

phosphorylation event can be examined independently and in conjuction with each
other. More specifically, does Kin28 physically associate with termination factors
because both are binding to the CTD in close proximity? Given that the length of the
yeast CTD can wrap entirely around RNAP II, it is not known if the specific
phosphorylation marks have to be within the same 11 residue functional unit. It is
necessary to create mutants where only one of the serines can be phosphorylated in
isolation from the others to rule out that the proximity of marks on the CTD is a
stabilizing factor.
IV. 3. SPECULATIONS
It is interesting to contemplate how gene loops are actually formed from the
correct juxtaposition of a specific terminator with its own promoter. How does a
terminator know which promoter to associate with? According to Peter Cook, RNAP II
never really escapes the promoter in vivo and instead pulls the DNA through it as it
transcribes (177). So, promoter DNA remains in contact with the PIC and so does the
elongating polymerase as it progresses to the terminator. This implies that formation of
a gene loop begins during the elongation step of transcription. Upon reaching the
terminator, this would bring that region into juxtaposition with the promoter and a
bonified gene loop could be stabilized during termination. Further rounds of reinitiation
would then form ‘elongation loops’ within the promoter-termination gene loop. Perhaps
the ‘background’ signal in CCC analysis within a gene reflects this concept, especially
where it concerns the intron/exon borders which indicate there are regions within a gene
that associate with the promoter and terminator regions during transcription (217).

94

The role of TFIIH in gene looping can also be further highlighted with regard to its
function in DNA repair. Work from other labs have shown that during transcription
coupled DNA repair, the region of DNA being repaired is recruited to the nuclear pore.
This recruitment also leads to the transcription of otherwise inactive genes during their
repair. This coincides with work from the Proudfoot lab that demonstrated that gene
loops are dependant on nuclear pore localization (283). Perhaps TFIIH is the key
player, where once it is recruited to the promoter or a site of damage, this invokes a
shuttle mechanism to the nuclear pore. Transcription could then stabilize the formation
of an elongation loop inititating through TFIIB phosphorylation, which occurs
immediately after CTD-serine-5 phosphorylation (297). This mechanism also implies the
existence of various ‘short circuits’ to transcription initiation that can bypass the usual
progression of PIC formation dictated by the mediator response to gene specific
activators.
In support of this ‘short circuit’ hypothesis, is the phenomenon of intron mediated
enhancement of transcription (IME). The insertion of an intron into a repressed gene
causes it to switch to into a fully on state with regard to transcription. This could occur
due to transcription initiating from the distal ends of a gene, which occurs during basal
and anti-sense transcription. If RNAP II transcribes to the intron without being
destabalized, this would recruit the splicing machinery, and then the gene switches to
an ‘elongation loop’ mode that leads to gene loop formation and the full on state for that
gene. This would also explain why IME functions based on the proximity of the intron to
the distal ends of a gene.
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APPENDIX A: EXPERIMENTAL PROCEDURES
A.1.1 CELL CULTURE (RT-PCR, 3C, ChIP or TRO)
Cell cultures were began from fresh plates (less than 3 weeks) in 5ml tubes in
either YP-dextrose or synthetic Ura- drop out media. Cultures were grown at 30 °C for
6-7 hours until evening and diluted 1:100 into 100 ml flasks of similar media. 100 ml
flasks were grown overnight and the optical density was measured the next morning on
a spectrophotometer at wavelength 600 nm (OD600). If cultures were overgrown, OD600
>0.6, cultures were diluted in similar media down to an OD 600~0.3 and grown to an
OD600~0.4 to 0.6 depending on the experiment and genes being examined. Cultures
were then transferred to appropriate media for induction of 1-2 hours. For MET16,
CHA1 or HXT1 cells were grown to an OD600~0.5 and induced for 1 hour unless
specified for a time course. For INO1 and GAL10 cells were grown to an OD 600~0.4 and
induced for 2 hours unless specified for a time course. For induction using the kinase
inhibitor NA-PP1, 6um final concentration in DMSO was used when the cells were
transferred into induction media. For induction using strains that are temperature
sensitive, cells were grown at the permissive temperature of 25 °C to an OD600~0.4 to
0.6 and then transferred to the non-permissive temperature of 37 °C for 2 hours unless
specified otherwise. After induction the cells were then processed accordingly for each
experiment.
A.1.2 CELL CULTURE (CO-IP, Glycerol Gradient, FPLC)
Cell cultures were began from fresh plates (less than 3 weeks) in 5 ml tubes in
either YP-dextrose or synthetic Ura- drop out media. Cultures were grown 6-7 hours
until evening and diluted 1:200 into 1L flasks of similar media. 1L flasks were grown
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overnight and optical density was measured the next morning on a spectrophotometer
at wavelength 600nm (OD600). If cultures were overgrown, OD600 >2.0, cultures were
diluted in similar media down to an OD600~0.6 and grown to an OD600~1.2 to 1.5. If cells
were being induced the cells were transferred at an OD 600~1.0 into 1L flasks of
appropriate media and allowed to grow for an additional 1-2 hours before being
processed for the experiment.
A.2 RT-PCR
Cells were grown as above. Cell pellets were washed with 5 ml DEPC treated water.
Cells were transferred to 1.5 ml lock top tubes using 500 l of Trizol. 250 l of acid
washed glass beads were added and cells were lysed by vortexing for 30 mintues at 4
°C. Tubes were then punctured using a 22 gauge needle and drained into 15 ml tubes
by centrifugation for 2 minutes at 2k rpm at 4 °C. Lysate was transferred to a fresh 1.5
ml eppendorf and 500 ul of Trizol was added and incubated for 5 minutes at 25 °C. 200
l of chloroform was added and mixed by vortexing, then centrifuged for 15 minutes at
14k at 25 °C. The supernatant was transferred to a another eppendorf and three RNA
phenol chloroform extractions were performed. The RNA was precipitated by adding 0.1
volume of LiCl and 2.5 volumes of 100% EtOH and centrifuging for 20 minutes at 14k at
25 °C. The RNA pellet was resuspended in 51 l of DEPC treated water and the
quantity was measured using a nanodrop. The RNA concentration was adjusted to 100
ng/l. Mulv reverse transcriptase was used to make cDNA using oligo-dT and 18S
cDNA primers. Reactions were incubated using a thermocycler for the extension and
deactivation steps. A negative control without reverse transcriptase was performed to
ensure no DNA contamination contributed to any RT- PCR signal. cDNA was diluted
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prior to PCR amplification by the addition of 180 l of 1x TE. The gene specific PCR
primers used are listed in appendix C. Each PCR was normalized against the 18S
ribosomal RNA control.
A.3 STANDARD REVERSE TRANSCRIPTION REACTIONS (RT-PCR or TRO)
Reverse transcription reactions were all performed using Mulv reverse
transcriptase (NEB). 10 l of diluted RNA (as specified in either RT-PCR or TRO) was
incubated with either 2 l of oligo dT (25 [pM]) or gene specific primer at 65 °C for 5
minutes followed by 4 °C for at least 2 minutes. To each sample, 8 ul of a master mix (4
l H20, 2 l of 10x Mulv buffer, 1 l of dNTPs (NEB), 1 l of Mulv RT enzyme) was
added. Samples were then incubated in a thermocycler at 37 °C for 45 minutes followed
by inactivation at 65 °C for 20 minutes and then held at 4 °C. cDNA for RT analysis was
diluted with the addition of 180 l 1x TE and cDNA for TRO analysis was diluted °C with
the addition of 80 l of 1x TE.
A.4 STANDARD PCR REACTIONS (RT-PCR, 3C, ChIP or TRO)
All PCR reactions were performed using Taq polymerase (NEB). Each PCR was
performed as a 25 l reaction using 16.5 l water, 2.5 l of 10x Taq polymerase buffer
(NEB), 0.5 l of dNTPs (NEB), 0.5 l of Taq polymerase enzyme (NEB), 2 l of a premixed primer pair (5 l of each primer from 250 [pM] stock and 190 l water) and 3 l of
template (either DNA or cDNA). For a first round analysis, a 30 cycle reaction would be
performed followed by gel electrophoresis. Based on the initial band strength
determined using the Kodak 1D software, other reactions would be performed in order
to get band strengths in the 3000 to 80000 linear range for quanfification. If one of the
primer pairs was either extremely strong or weak, either a different pair was chosen or it
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was run separately for the necessary cycles to adjust the intensity into same range with
the rest. For input or 18S normalization controls 26-29 reaction cycles were used
(usually on the lower end). For ChIP and RT PCR using gene specific primers 28-32
reaction cycles were used. For TRO and CCC the signals were often hard to see and
required 33 to 36 reaction cycles to amplify quantifiable bands using 6 l of template
instead of the normal 3 l. Quantification of band signals was performed as described
below.
A.5 TRANSCRIPTION RUN-ON ASSAY (TRO)
Cells were grown as described above. The transcription run-on assay was
performed as described in Al Husini et al., 2013. 50 ml of cells were harvested after
induction at an OD600~0.8. The cell pellet was washed with 10 ml of ice cold TMN buffer
(10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 100 mM NaCl) and resuspended in 940 μl of
DEPC (Diethylpyrocarbonate)-treated ice cold water. Cells were permeabilized by the
addition of 60 l 10% sarkosyl and incubated in an ice pack for 25 minutes while
nutating at 4 °C. Cells were pelleted again using low speed centrifugation 1.2g for 6
minutes at 4 °C. In vivo transcription elongation was then performed by suspending the
cells in 150 l of reaction buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 10 mM MgCl2, 2
mM DTT, 0.75mM ATP, CTP, GTP and Brd-UTP, with 5 l RNAse inhibitor cocktail
NEB). To allow for proper elongation, the reactions were incubated at 30 °C for 5
minutes. The elongation reaction was immediately stopped with the addition of 500ul of
ice cold Trizol reagent (Sigma). Cells were then lysed with 250 l acid washed glass
beads (Sigma) for 20 minutes using a vortex at 4 °C. The tubes were punctured using a
22 gauge needle and drained into 15 ml tubes by spinning 2k rpm at 4 °C. The lysate
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was transferred to a 1.5 ml eppendorf and 500 l of Trizol was added and incubated at
25 °C for 5 minutes. 200ul of chloroform (Sigma) was added and the tubes were
vortexed briefly and centrifuged for 20 minutes at 14k rpm at 25 °C. Approximately 700
l of supernatant was transferred to another 1.5 ml eppendorf tube and 700 l of RNA
phenol chloroform pH 4.2 was added and vortexed briefly. Tubes were then centrifuged
for 15 minutes at 14k rpm at 25 °C. The RNA phenol chloroform extraction was
repeated 2x more to purify the RNA. Total RNA was precipitated with 1/16th volume of
5M NaCl and 2.5 volumes of 100% ethanol and incubated overnight at -20 °C. RNA was
pelleted by centrifugation for 20 minutes at 13.2k at 4 °C. The RNA pellet was washed
once with ice cold 70% EtOH and resuspended in 100 l of DEPC treated water.
A bed volume of 25 l Anti-BrdU conjugated agarose beads (Sigma) were
washed 3x using 500 ul of binding buffer (0.25x SSPE buffer, 1mM EDTA, 0.05%
Tween20, 37.5 mM NaCl). Beads were blocked using 500 l of blocking buffer (485 l
binding buffer, 5 l of 10% polyvinylpyrolidone, 10 l of Ultrapure BSA, Sigma) by
nutating for 1 hour at 4 °C. RNA was further purified using the Qiagen RNA Easy kit and
eluted twice with 50 l of DEPC treated water. Beads were washed 2x using 500 l of
binding buffer and then 400 l of binding buffer was added to the beads and placed on
ice. The eluted RNA was incubated at 65 °C water bath for 5 minutes and immediately
placed on ice for 2 minutes. The RNA was then added to the beads and bound by
nutating for 2 hours at 4 °C. Beads were then washed sequenctially using 500 ul of
binding buffer, 500 l of low salt buffer (0.2x SSPE, 1 mM EDTA, 0.05% Tween20) 500
l of high salt buffer (0.25x SSPE, 1 mM EDTA, 0.05% tween20, 100 mM NaCl) and
500 l of TET buffer (1x TE buffer, 0.05% tween20). RNA was eluted 2x with 150 l of
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elution buffer (20 mM DTT, 150 mM NaCl, 50 mM Tris-HCl ph 7.5, 1 mM EDTA, 0.1%
SDS) by incubating at 42 °C for 5 minutes followed by a final elution with 200 l of
elution buffer at 42 °C for 5 minutes. To the 500 l of elution, 500 l of RNA
phenolchloroform ph 4.2 was added and vortexed and then centrifuged for 15 minutes
at 14k rpm at 25 °C. Supernatent was transferred to fresh 1.5 ml eppendorf and RNA
was precipitated with 0.1 volume LiCl and 2.5 100% EtOH by centrifugation for 20
minutes at 14k rpm at 25 °C. RNA was resuspended in 26 l of DEPC treated water and
the quantity was measured using a nanodrop. RNA concentration was adjusted to 50
ng/l or the lowest concentration in the set. cDNA was made using strand specific
primers listed in appendix C. The primers were designed to synthesize cDNA at a
region just 3’ of the open reading frame, the region near the poly (A) signal, and two
more regions over 100 bp downstream from the poly (A) signal.
A.6. CHROMATIN IMMUNOPRECIPITATION (ChIP)
Cells were grown as described above. Cell cultures were crosslinked by adding
1% formaldehyde and shaking for 20 minutes at 25 °C. Crosslinking was quenched by
the addition of 125 mM Glycine and shaking for 5 minutes at 25 °C. The cells were
transferred to 50 ml conical tubes and pelleted by centrifugation at 3k rpm for 5 minutes
at 4 °C. Cell pellets were washed with 10 ml of ice cold cell wash buffer (1x TBS, 1%
Triton X100). Cells were transferred to 1.5 ml lock top tubes with 500 l of FA lysis
buffer (50 mM Hepes-KOH ph 7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
Na deoxycholate, 1 mM PMSF). 250 l of acid washed glass beads were added and the
cells were lysed by vortexing for 30 minutes at 4 °C. The tubes were punctured with a
22 gauge needle and drained into 15 ml tubes by centrifugation for 2 minutes at 2k rpm
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at 4 °C. The lysate was transferred to a 1.5 ml eppendorf tube and centrifuged for 15
minutes at 13.2k rpm at 4 °C. The pellet was washed with 500 l of FA lysis buffer and
then transferred to a 15 ml tube with 4ml of FA lysis buffer. Sonication was performed
with the Branson digital sonifier and a 2 mm probe. Lysates were sonicated while
suspended in an ice water batch at 25% duty cycle using 20 second pulses followed by
20 second rest, for a total sonication time of 12 minutes. Sonicated lysate was then
transferred into 1.5 ml eppendorf tubes and centrifuged for 15 minutes at 13.2k at 4 °C.
Chromatin supernatents were then pooled per sample and aliquoted into 400 l
amounts to be used for Input or immunoprecipitation.
For ChIP experiments in strains harboring a C-terminal Myc tagged protein, antiMyc conjugated agarose beads (Sigma) were used. For ChIP experiments in strains
harboring a C-terminal HA tagged protein, anti-HA conjugated agarose beads (Pierce)
were used. For ChIP experiments in strains harboring a C-terminal TAP tagged protein,
IgG conjugated agarose beads (GE healthcare) were used. For ChIP experiments
involving the use of antibodies against a selected protein, protein-A conjugated agarose
beads (Sigma) were used. For CTD ChIP experiments, the antibodies for Ser2, Ser5
and Ser7 phosphorylation were 3E10, 3E8 and 4E12 respectively (Millipore). 800 l of
chromatin was incubated for 4 hours using 5 ul (or 20 l for 4E12) of antibody with
gentle shaking at 4 °C prior to incubation with the agarose beads.
A bed volume of 20 ul of beads was washed three times with 500 l of FA lysis
buffer. 800 l of chromatin was added to the beads and incubated overnight with gentle
shaking at 4 °C. Beads were then spun gently for one minute at 1.5k rpm at 25 °C. All of
the subsequent washing steps were performed at 25 °C. Supernatent was removed and
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the beads were washed 2x with 1 ml FA lysis buffer containing 0.1% SDS. The beads
were then washed 2x with 1ml FA lysis buffer containing 500 mM NaCl and 0.1% SDS.
The beads were then washed 2x with 1ml ChIP wash buffer (10 mM Tris-HCl pH 8.0,
250 mM LiCl2, 0.5% Na deoxycholate, 1 mM EDTA, 0.5% tergitol, 0.1% SDS). The
beads were then washed with 1 ml of 1x TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA).
Purified chromatin was eluted 2x with 200 ul of elution buffer (50 mM Tris-HCl pH 7.5,
10 mM EDTA, 1% SDS) by incubating at 65 °C for 10 minutes.
Eluted samples and input were then treated with 10 g of RNAse A by incubation
at 37 °C for 15 minutes. For input samples 0.1% SDS was added. Samples were
treated with 20 g proteinase K at 42 °C for 90 minutes. Reversal of crosslinking was
done by incubating samples at 65 °C for overnight (or 6 hours minimum). DNA was
purified by performing 2x DNA phenol chloroform pH 7.5 extractions. The DNA was
precipitated by EtOH precipitation using 0.1 volume Na Acetate and 2.5 volumes EtOH
and 2 l of glycogen as a carrier and also to aid in visualizing the pellet. For every batch
of sonicated chromatin, one set of input was resuspended in 20 l of 1x TE and 3 l of
10x loading dye to verify DNA fragment size was below 500 bp by gel electrophoresis.
Input was resuspended in 101 l 1x TE and immunoprecipitated (IP) samples were
resuspended in 51 l of 1x TE and the quantity was measured using a nanodrop. Inputs
were routinely normalized to 100 ng/l and IP samples were normalized to 50 ng/ul or to
the lowest concentration in the set of IP samples. The primers used for PCR analysis
were chosen based on the region of a gene to detect and to be of similar sized
amplicons when possible. The primers used for ChIP PCR analysis are in appendix C.
A.7. CHROMOSOME CONFORMATION CAPTURE ANALYIS (3C)
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Cell cultures were grown as described above (A.1). Crosslinking was performed
by the addition of 1% formaldehyde and incubation for 30 minutes at 25 °C with gentle
shaking. Crosslinking was quenched by the addition of 125 mM Glycine and shaking for
5 minutes at 25 °C. The cells were transferred to 50 ml conical tubes and pelleted by
centrifugation at 3k rpm for 5 minutes at 4 °C. Cell pellets were washed with 10 ml of ice
cold cell wash buffer (1x TBS, 1% Triton X100). Cells were then washed again with 10
ml of ice cold 1x TBS). Cells were transferred to 1.5 ml lock top tubes with 500 ul of FA
lysis buffer (50 mM Hepes-KOH ph 7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100,
0.1% Na deoxycholate, 1 mM PMSF). 250 l of acid washed glass beads were added
and the cells were lysed by vortexing for 30 minutes at 4 °C. The tubes were punctured
with a 22 gauge needle and drained into 15 ml tubes by centrifugation for 2 minutes at
2k rpm at 4 °C. The lysate was transferred to a 1.5 ml eppendorf tube and centrifuged
for 15 minutes at 13.2k rpm at 4 °C. The pellet was resuspended in 1ml of ice cold FA
lysis buffer with 0.1 % SDS and incubated at 4 °C with gentle shaking. Samples were
then centrifuged for 15 minutes at 13.2k rpm at 4 °C and the pellet was resuspended in
1 ml FA lysis buffer and incubated for 10 minutes at 4 °C with gentle shaking. Samples
were then centrifuged for 15 minutes at 13.2k rpm at 4 °C and the pellet was
resuspended in 1 ml of ice cold water and centrifuged again similarly. Washed pellets
were then resuspended in 500 l of TM buffer (10 mM Tris-HCl pH 7.5, 5 mM MgCl2)
and aliquotted in 45 l amounts in 1.5 ml flat eppendorf tubes. Samples were flash
frozen in liquid nitrogen and stored at -80 °C until use.
5 l of 10% SDS was added to each 45 l sample and incubated for 30 minutes
at 37 °C with gentle shaking, followed by the addition of 8 l of 10% Triton X-100 and 12
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ul of water and another incubation for 30 minutes at 37 °C with gentle shaking. 10 l of
10x restriction enzyme buffer (3.1 or cutsmart, NEB) and 10 l each of AluI and NlaIV
(10 U/l, NEB) were added to each sample and incubated at 37 °C for 6 hours with
gentle shaking. An overnight double digestion was then performed by the addition of 70
l water, 10 l of 10x restriction enzyme buffer and another 10 l of each enzyme
followed by an overnight incubation at 4 °C with gentle shaking.
The next morning inactivation was performed by the addition of 5 l of 10% SDS
and incubation at 65 °C for 30 minutes. The SDS was then chelated by the addition of
75 l of 10% Triton X-100 and 95 l of water followed by incubation for 30 minutes at 37
°C with gentle shaking. Ligation was performed by the addition of 375 l of 2x Quick
Ligation Buffer (NEB) and 5 l of Quick Ligase enzyme and incubation for 90 minutes at
25 °C with gentle shaking. Proteins were then digested by the addition of 7.5 l of 10%
SDS, 20 l of 5M NaCl and 5 l of 20 mg/ml proteinase K followed by incubation for 2
hours at 42 °C. 10 l of additional proteinase K was then added to each sample and
crosslinks were reversed by incubation overnight at 65 °C. The next morning DNA was
purified by 3x DNA phenol chloroform pH 7.5 extractions. The supernatant was then
transferred to a 2 ml microcentrifuge tube and the DNA was precipitated by EtOH
precipitation using 0.1 volume 3 M Na acetate pH 5.2 and 2.5 volumes 100% EtOH and
2 l of 20 mg/ml glycogen followed by centrifugation for 30 minutes at 14k rpm at 25 °C.
The DNA pellet was then resuspended in 51 l of 1x TE and quantity measured on a
nanodrop. The concentration was then adjusted to either 100 ng/l or the lowest
concentration in the set of tubes. Gene specific primers were then chosen in order to
identify promoter terminator interactions by a specific length ligation product. Control
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primers spanning undigested regions were used to normalize 3C PCR signals against.
The primers used for PCR analysis are listed in appendix C.
A.8. CO-IMMUNOPRECIPITATION (CO-IP)
Cells were grown as described above (A.1.2). Each liter of culture was split into 2
500 ml centrifuge tubes and centrifuged at 3k rpm for 5 minutes at 4 °C. The cell pellet
obtained was washed once with 50 ml of ice-cold 1x TBS buffer containing 1% Triton X100 and centrifuged again. The cell pellet was then washed with 50 ml of ice cold water
and transferred to 50 ml conical tubes and centrifuged at 3k rpm for 5 minutes at 4 °C.
The pellet (usually close to 7 ml) was resuspended in 9 ml of IP lysis buffer (20 mM
Tris-HCl pH 8.0, 150 mM KCl, 0.5 mM EDTA, 1 mM MgCl2 , 0.1% Triton X-100, and 1
mM PMSF) and flash frozen drop by drop using an automated pipet in liquid nitrogen.
The frozen cell pellet was homogenized to a very fine powder using a liquid nitrogen
chilled mortar and pestle, transferred to a beaker, and allowed to thaw slowly on ice.
The resulting cell lysate was centrifuged at 16,400 rpm for 20 min in a Sorvall SS-34
rotor, and the supernatant was transferred to a 15 ml tube. A 200 l aliquot was
transferred to a 1.5 ml eppendorf and 50 ul of 5x laemmli buffer (50% glycerol, 25% 2mercaptoethanol, 10% SDS, 300 mM Tris-HCl pH 6.8, 0.01% bromophenol blue) was
added to be used for input
For CO-IP experiments in strains harboring a C-terminal Myc tagged protein,
anti-Myc conjugated agarose beads (Sigma) were used. For CO-IP experiments in
strains harboring a C-terminal HA tagged protein, anti-HA conjugated agarose beads
(Pierce) were used. For CO-IP experiments in strains harboring a C-terminal TAP
tagged protein, IgG conjugated agarose beads (GE healthcare) were used. For CO-IP
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experiments using anti-TFIIB antibodies, 50 l of antiserum was bound with lysate for 1
hour at 4 °C with gentle agitation prior to incubation with protein A Sepharose beads
(GE healthcare). A bed volume of 50 l of affinity beads was washed 3x with IP lysis
buffer prior to binding. For the MNase controls, the cell lysate was incubated with 300
units of MNase at 37 °C for 30 min prior to binding to the affinity beads. For the high salt
controls, the IP lysis buffer was prepared as described above using a 500 mM KCl
concentration.
Cell lysate was used to transfer the beads back into the 15 ml tube for binding.
The binding was performed at 4 °C for 4 hours with gentle shaking. Following binding,
the 15 ml tubes were centrifuged at 1k rpm for 2 minutes at 4 °C and another 200 ul
aliquot was removed from the supernatant for flow through, the remaining supernatant
was discarded. The beads were transferred to microcentrifuge tubes and washed five
times with 1 ml each of IP wash buffer (20 mM Tris-HCl, pH 8.0, 50 mM KCl, 0.5 mM
EDTA, 1 mM MgCl 2 , 1 mM PMSF, and 0.1% Triton X-100).
Elution was performed by one of three methods depending on the experiment
and the affinity tag used for immunoprecipitation. For experiments that only required
further SDS PAGE and Western blot analysis, elution was performed by using Laemmli
buffer directly. For experiments that required further analysis by glycerol gradient
sedimentation or FPLC analysis elution was performed with specific peptides for either
cMyc or HA tags; or using proteolytic cleavage of the TAP tag.
For elution with Laemmli buffer, 200 l of water and 50 l of 5x Laemmli buffer
was added to the beads. The samples were eluted by incubating for 15 minutes at 25
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°C with gentle shaking. The samples were then centrifuged at 1.5k for 2 minutes at 25
°C and the supernatents were transferred to1.5 ml eppendorf tubes.
For elution with HA or c-Myc oligopeptides (Genscript), 200 l of oligopeptide
elution buffer (see below) was added to the beads and incubated for 30 minutes at 25
°C with gentle shaking. Due to the different number of peptide repeats in each Cterminal tag, 3x HA and 13x c-Myc, the concentrations for each oligopeptide were
adjusted for elution. The HA-oligopeptide elution buffer used a concentration of 100
mg/ml in IP lysis buffer, and the c-Myc oligopeptide elution buffer used a concentration
of 500 mg/ml in IP lysis buffer. After elution, samples were centrifuged at 1.5k rpm for 2
minutes at 25 °C and the supernatant was transferred to a 1.5 ml eppendorf tube and
kept on ice to be used for either glycerol gradient sedimentation or FPLC analysis.
For elution against a TAP tagged protein using proteolytic cleavage, TurboTEV
(MC Labs) was used against the TEV sequence in the TAP tag. The elution was
performed by the addition of 195 l of IP lysis buffer (worked better than the supplied
buffer) with 2 mM DTT and 5 l of TurboTEV enzyme followed by incubation either for
60 minutes at 25 °C, or overnight at 4 °C. After elution, samples were centrifuged at
1.5k rpm for 2 minutes at 25 °C and the supernatant was transferred to a 1.5 ml
eppendorf tube and kept on ice for further use.
A.9 SDS PAGE and WESTERN BLOTTING
Eluted samples containing 1x Laemmli buffer were first heated for 20 minutes at
95 °C prior to loading. 10% gels were prepared using 1.5 mm premade cassettes
(Invitrogen). The eluted proteins were separated by SDS-PAGE and transferred to a
polyvinylidene difluoride (PVDF) membrane using an Amersham Biosciences TE70
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semi-dry transfer apparatus. Following transfer, the membrane was additionally blocked
by submerging in 100% methanol for a few seconds and then allowed to either dry
overnight or in the 65 °C oven for 15 minutes. 14 ml of antibody solutions were prepared
in 1x TBS with 0.25 g of nonfat dry milk according to manufacturer recommended
dilutions for western blotting. For primary antibodies 140 l of 1% sodium azide was
added as a preservative and primary solutions were used for up to 3 months. Blotting
was performed by incubating the membrane protein side down in the antibody solution
for 1-2 hours, followed by two 5 minute washes in 1x TBS with gentle shaking. The
protein bands were visualized using the Pierce Pico chemiluminescent reagents.
A.10 ACTIVATOR-TFIIB CO-IP
For coimmunoprecipitation using HA-tagged transcription activators, the cells
were grown in 1 liter of appropriate medium to an A 600 of 1.0–1.2 and then induced for
2 h. Cross-linking was performed by incubating the cells in formaldehyde (final
concentration, 0.5%) for 20 min, and the reaction was stopped by the addition of glycine
(final concentration, 125 mM ). The cell pellet was washed and lysed as described
above. Cell lysate was subjected to sonication (30 pulses of 10s each at 25% duty cycle
with 30s rest in between). The resulting cell lysate was centrifuged at 16,400 rpm for 20
min in a Sorvall SS-34 rotor. The supernatant was used for immunoprecipitation. One
sample of the cell lysate, grown under induced conditions, was pre-treated with 10 units
of micrococcal nuclease (WorthingtonLabs) for 30 min at 37 °C prior to binding. A 1-ml
aliquot of the micrococcal nuclease-treated cell lysate was checked for complete
digestion of chromatin by running on 1.5% agarose gel following deproteinization and
crosslinking removal of samples.
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A.11. GLYCEROL GRADIENT SEDIMENTATION
Affinity-purified samples were pipette mixed with an equal volume of ice-cold IP
lysis buffer without glycerol and incubated for 20 min on ice. For each sample 20 ml of
IP lysis buffer with 5% glycerol and 30% glycerol were prepared. Gradient analysis was
performed in Seton 25 mm x 89 mm polyallomer tubes by first layering 19.5 ml of IP
lysis buffer with 5% glycerol on the bottom using a syringe. Then carefully adding to the
bottom, 19.5 ml of IP lysis buffer with 30% glycerol using a syringe placed in the center
of the tube. The gradient tubes were then mixed on a Biocomp gradient master to
create linear gradients using the settings: Time 1:30 seconds, Angle 75 degrees and
Speed 25. The purified samples were loaded on the top of the gradient by pipetting
slowly and touching the drops to the surface. The samples were then immediately
centrifuged at 30,000 rpm for 18 h at 4 °C. Fractions of 1.8 ml each were collected
manually using a Beckman fraction recovery system by puncturing the bottom, and 40
ul of each fraction was used for SDS PAGE and Western blotting.
A.12. FAST PRESSURE LIQUID CHROMATOGRAPHY (FPLC)
Affinity purified samples were combined from 4L of culture into a 1ml eppendorf
tube. Sample was loaded into a 1 ml loop on the FPLC machine and a custom program
was used to automate the collection of 1 ml fractions following passage of the void
volume (39 ml). 54 fractions were collected after size exclusion chromatography using a
superdex 200 column. Chromatography was performed using IP lysis buffer.
A.13 YEAST STRAIN CREATION
All yeast strains were created following a Lithium acetate transformation protocol.
Cells were grown to an OD600~0.6 and washed with 10 ml of ice cold Lithium acetate
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buffer (100 mM LiOAc, 10 mM Tris-HCl pH 8.0, 1 mM EDTA). Cells were transferred
with 100 l of ice cold Lithium acetate buffer into eppendorf tubes containing the
construct DNA and gently shaken for 5 minutes at 25 °C. The construct DNA was
created from PCR using the high fidelity advantage enzyme and gene specific primers
coupled with a tag or knock out plasmid listed in appendix C. Cells were then incubated
with 280 l of PEG solution (50% PEG 4000,100 mM LiOAc, 10 mM Tris-HCl pH 8.0
and 1 mM EDTA) for 45 minutes at 25 °C. Cells were then heat shocked with the
addition of 43 l DMSO for 5 minutes at 42 °C and immediately transferred to ice for at
least 2 minutes. Cells were then centrifuged at 4k rpm for 30 seconds at 25 °C and the
pellet was washed with 500 l of either sterile water or media. For transforms using
kanamyacin, cells were allowed an outgrowth period of two hours in non-selective
media prior to plating. Cells were then resuspended and plated on selective plates.
Colonies were isolated and positive transformants were screened by gene specific
primers to verify the strain.
A.14 CLONING AND PURIFICATION OF RECOMBINANT TFIIB
The gene coding for yeast TFIIB, SUA7, was cloned into the NdeI-EcoRI sites of
pET24a. Recombinant plasmid was transformed into the BL21 strain of Escherichia coli.
Induction of recombinant TFIIB and preparation of cell lysate were performed as
described by Ansari and Schwer (14). His-tagged TFIIB was affinity-purified on a Cobalt
resin (Pierce Scientific) following the manufacturer’s guidelines.
A.15. QUANTIFICATION
Initial quantification was performed using two independent replicas of each
experiment followed by two rounds of PCR. For each PCR reaction, lanes were loaded
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on duplicate gels in order to account for human pipetting error while loading. For each
set of gels to be quantified following PCR, fresh agarose was prepared and all gels
were poured at once in order to avoid differences in gel density when staining with
ethidium bromide. Gels were stained for 20 minutes in a fresh solution of 200 ml 1x TAE
with 10 ul of ethidium bromide (10 mg/ml). The signal strength of gel bands was
analyzed using the Kodak Gel Logic 200 system after 2 second exposure. Pictures were
analyzed using the Kodak 1D software to calculate the net intensity. The net intensities
were then used to calculate a ratio of the signal of interest / control, and these ratios
were averaged and the standard deviation was calculated. If standard deviations
overlapped or displayed large variation, first another round of PCR and quantification
was performed and averaged in. If there were still large standard deviations, a third
replica experiment was performed and analyzed.
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APPENDIX B: STRAINS
B.1. STRAINS USED IN CHAPTER II
Strain
genotype
FY23
SSR2

Reference

MATa ura3-52 trp163 leu21

Madison and Winston,
1997 (1)
MATa ura3-52 trp163 leu21, MET28- Kaderi et al, 2009
3xHA, KanMX

SAM6

MATa
ura3-52
Δmet28::KanMX

trp1Δ63

BY4733

MATa
his3200
met150 ura30

SRR3

MATa
his3Δ200
trp1Δ63
leu2Δ0 Kaderi et al, 2009
met15Δ0 ura3Δ0, INO2-3xHA, KanMX

BEK3

MATa
his3Δ200
trp1Δ63
met15Δ0 ura3Δ0 Δino2::KMX

YMH867

MATa leu2-3 can1-100 ura3-1 ade2-1 Ansari and
his3-11,15 trp1-1 GAL1 promoter 2005 (2)
upstream of BUD3, HIS3+

SRR4

MATa leu2-3 can1-100 ura3-1 ade2-1 Kaderi at al, 2009
his3-11,15 trp1-1, Gal1p-BUD3, HIS+,
GAL4-3xHA, KanMX

SAM4

MATa leu2-3 can1-100 ura3-1 ade2-1 Kaderi at al, 2009
his3-11,15 trp1-1,Gal1p:BUD3, HIS+,
Δgal4::KMX

SRR1

MATa leu2-3 can1-100 ura3-1 ade2-1 Kaderi at al, 2009
his3-11,15 trp1-1,Gal1p-BUD3, HIS+,
RNA15-TAP,TRP+

AA1

MATα ura3-1 trp1-1 ade2-1 leu2-3,112 Medler et al, 2011
his3-11,15 rna14-1 SUA7-TAP, TRP+

AA2

MATa ade1/ade2 lys2 ura3-52 pap1-1 Medler et al, 2011
SUA7-TAP, TRP+

SRR7

MATa
his3Δ200
met15Δ0 ura3Δ0
RNA14-TAP, URA+

trp1Δ63

leu2Δ0 Medler et al, 2011

SRR8

MATa
his3Δ200
met15Δ0 ura3Δ0
PCF11-TAP, URA+

trp1Δ63

leu2Δ0 Medler et al, 2011

trp163

leu2Δ1, Kaderi et al, 2009
leu20 Hampsey lab

leu2Δ0 Kaderi et al, 2009
Hampsey,
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SAM50

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, RNA14-13xMyc, TRP+

SAM51

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, RNA15-13xMyc, TRP+

SAM52

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, PCF11-13xMyc ,TRP+

SAM53

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, CLP1-13xMyc, TRP+

SAM54

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, HRP1-13xMyc, TRP+

SAM55

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, PAP1-13xMyc, TRP+

SAM56

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+

SAM58

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+,
RNA14-13xMyc, TRP+

SAM59

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+,
RNA15-13xMyc, TRP+

SAM60

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+,
PCF11-13xMyc ,TRP+

SAM61

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+,
CLP1-13xMyc, TRP+

SAM62

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+,
HRP1-13xMyc, TRP+

SAM63

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+,
PAP1-13xMyc, TRP+

YMH14

MATα cyc1-5000 cyc7-67 ura3-52 leu2- Pinto, 1994
3,112 cyh2

YMH124

MATα cyc1-5000 cyc7-67 ura3-52 leu2- Pinto, 1994
3,112 cyh2 sua7-1

SAM64

MATα cyc1-5000 cyc7-67 ura3-52 leu2- Medler et al, 2011
3,112
cyh2
sua7-1,
SUA7-3xHA,
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KANMX
SFS1

MATα cyc1-5000 cyc7-67 ura3-52 leu2- Medler et al, 2011
3,112
cyh2
sua7-1,
SUA7-3xHA,
KANMX, PCF11-13xMyc, TRP+

SFS2

MATα cyc1-5000 cyc7-67 ura3-52 leu2- Medler et al, 2011
3,112
cyh2
sua7-1,
SUA7-3xHA,
KANMX, PAP1-13xMyc, TRP+

SFS3

MATα cyc1-5000 cyc7-67 ura3-52 leu2- Medler et al, 2011
3,112
cyh2
sua7-1,
SUA7-3xHA,
KANMX, RNA15-13xMyc, TRP+

SAM68

MATa
his3Δ200
trp1Δ63
leu2Δ0 Medler et al, 2011
met15Δ0 ura3Δ0, TBP-3xHA, HIS+

YMH804

MATa ura3 leu2 trp1 his3 ade2 ade3 Hampsey lab
can1 kin28Δ::trp1 (pKIN28-HA)

SHY407B

MATα ade2Δ his3Δ200 leu2Δ0 met15Δ0 Rani, 2004
trp1Δ ura3Δ0 RPB9-Flag1-TAP::TRP1

rna14-1

MATα ura3-1 trp1-1 ade2-1 leu2-3,112 Minveill-Sebastia, 1994
his3-11,15 rna14-1

AA1

MATα ura3-1 trp1-1 ade2-1 leu2-3,112 Medler et al, 2011
his3-11,15 rna14-1 SUA7-TAP, TRP+

pcf11-2

MATa ura3-1 trp1Δ ade2-1 leu2-3,112 Amrani, 1997
his3-11,15 pcf11Δ::TRP1/pEL36-pcf11-2

NAH12

MATa ura3-1 trp1Δ ade2-1 leu2-3,112 Medler et al, 2011
his3-11,15 pcf11Δ::TRP1/pEL36-pcf11-2
SUA7-TAP, TRP+

hrp1-5

MATα cup1Δ ura3 his3 trp1 lys2 ade2 Kessler, 1997
leu2
hrp1::HIS3[pRS315-hrp1-L205S
(LEU2)]

NAH13

MATα cup1Δ ura3 his3 trp1 lys2 ade2 Medler et al, 2011
leu2
hrp1::HIS3[pRS315-hrp1-L205S
(LEU2)] SUA7-TAP, TRP+

pap1-1

MATa ade1/ade2 lys2 ura3-52 pap1-1

AA2

MATa ade1/ade2 lys2 ura3-52 pap1-1 Medler et al, 2011
SUA7-TAP, TRP+

B.2. STRAINS USED IN CHAPTER III

Patel, 1992
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BY4733

MATa his3200 trp163 leu20
met150 ura30

Hampsey lab

BPM5

MATa his3200 trp163 leu20
met150 ura30, TFB4-TAP, URA+

This study

SAM89

MATa his3200 trp163 leu20
met150 ura30, KIN28-TAP, URA+

This study

SAM90

MATa his3200 trp163 leu20
met150 ura30, SSL2-TAP, URA+

This study

SAM93

MATa his3200 trp163 leu20
met150 ura30, KIN28-TAP, URA+,
RNA15-13xMyc, TRP+

This study

SAM51

MATa his3Δ200 trp1Δ63 leu2Δ0
El Kaderi et al, 2009
met15Δ0 ura3Δ0, RNA15-13xMyc, TRP+

SAM94

MATa his3200 trp163 leu20
met150 ura30, KIN28-TAP, URA+,
SSU72-13xMyc, TRP+

SAM103

MATa his3Δ200 trp1Δ63 leu2Δ0
This study
met15Δ0 ura3Δ0, SSU72-13xMyc, TRP+

yFR763

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30

This study

Liu Y et al, 2004

kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G]
SAM99

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30

This study

kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G] Kin28as-TAP, TRP+
SAM101

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30
kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G] Kin28as-TAP, TRP+,

This study
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RNA15-13xMyc, HIS+
SAM102

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30

Pinto, 1994

kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G] Kin28as-TAP, TRP+,
SSU72-13xMyc, HIS+
SAM104

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30

This study

kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G] RNA15-13xMyc,
HIS+
SAM105

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30

This study

kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G] SSU72-13xMyc,
HIS+
SAM106

MATα, ade::higG, his3200, leu20,
lys20,met150,trp163,ura30
kin28::kin28-L83G [pSH579, ARS CEN
URA3 kin28-L83G] RPB4-13xMyc, HIS+

This study
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APPENDIX C: PRIMERS
C.1. RT Primers
cDNA
Name

Sequence

Oligo dT

TTTTTTTTTTTTTTTTTTTTTTTTT

18s

GACGGAGTTTCACAAGATTACC

CHA1 d1

GGAAAAAATCAATACTAGCAAAATA

CHA1 d2

GCTTTTCTTCACTTAGTAAGGATTAA

CHA1 d3

CTGGGGTCTTCATTTGTGTCA

ACT1 d1

GATAAAGTCAGTGCTTAAACACGTC

ACT1 d2

ATAAAACTGAAAAGCGATGAAGAG

ACT1 d3

TTTGCGTAACGTTTGGATGG

18s Control-PCR
Name

Sequence

18s F

GGAATAATAGAATAGGACGTTTGG

18s R

GTTAAGGTCTCGTTCGTTATCG

Gene Specific RT-PCR Primers
Name

Sequence

CHA1 F

AATTCAAAAGGACGGTAAAAGAT

CHA1 R

AAGGGATGAACATAAATGGGC

MET16 F

CATTTGGTTTGACTGGCTTGG

MET16 R

TCGTACTTGTCATCATCTTTCTCC

INO1 F

GATATCCAGAATTTCAAAGAAGAAAAC

INO1 R

TATTCTGCGGTGAACCATTAATATAG
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ACT1 F

TACTCTTTCTCCACCACTGCTG

ACT1 R

GATTTCCTTTTGCATTCTTTCG

MSN5 F

CAATGCCAATCCAAACAGTG

MSN5 R

CGCACTATTACACAGCACATTTA

CMP1 F

AACCGCAGAATAATGAATAAAGTG

CMP1 R

GATATAAGGTTGGGTTCTTTGCT

SPC1 F

GTGCTCTCGCTACTTTTCTGG

SPC1 R

CATTGTGCTGTTCAGAGAACCA

IMD4 F

ATTGGTATGGGTTCTGGGTC

IMD4 R

GCCTTCAATCTCTTACCATCC

ASC1 F

CTTACGCTTTGTCTGCTTCTTG

ASC1 R

GATGGTCTTGTCACGGGAAC

GAL10 F

GATCTTCCATACAAAGTTACGGG

GAL10 R

CACAAATCTTGCGTCATAACG

HXT1 F

ATTTGGTATGAAGCACCACGA

HXT1 R

GGGCGACCTCAGATATTAGCA

C.2. C-Terminal Tagging Primers
Name

Sequence

Gal4-HAtag-F2

ATAACTATCTATTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGA
G CGGATCCCCGGGTTAATTAA

Gal4-HAtag-R1

ATGCACAGTTGAAGTGAACTTGCGGGGTTTTTCAGTATCTACGATTCAT
T GAATTCGAGCTCGTTTAAAC

5’Gal4HA-tag-D

TGTGCGCCGTTTCTGTTATC
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Ino2-HAtag-F2

AGTCCATTAGAAGCGCAAATGAAGCACTACAGCACATACTGGATGATT
CC CGGATCCCCGGGTTAATTAA

Ino2-HAtag-R1

AAAATACATCCAACGGGAGGCCATTTTCATCACTAATAGCTTGTATGAG
C GAATTCGAGCTCGTTTAAAC

5’Ino2HA-tag-D

TTGTCTCCTTCCAGTTCGGG

Met28HA-tagF2
Met28HA-tagR1
5’Met28HA-tag-D

TTAAGTCTTTGAAATTGTTGAATGACATTAAGAGACGGAACATGGGCAG
G CGGATCCCCGGGTTAATTAA

F2-MycRNA14

TTTTAAATGATCAAGTAGAGATTCCAACAGTTGAGAGCA
CCAAGTCAGGTCGGATCCCCGGGTTAATTAA

ATCGAAGTTGGAGAGGAAAAACAAGACATCAGGCCCGCACGTTTCGC
GGG GAATTCGAGCTCGTTTAAAC
GGTGGGAAAAGAAATCAACAAAC

R1- Myc- AGATGTGTTGGTATAAATATTCATATATACCTATTTATTA
RNA14
ACGTAATGTTAGAATTCGAGCTCGTTTAAAC
F2- Myc- CTATTTGGGACTTAAAACAAAAAGCATTAAGGGGAGAA
RNA15
TTTGGTGCATTTCGGATCCCCGGGTTAATTAA
R1- Myc- ATCATTGCGGAACCGCATTTTTTTTTTGTATTTTTGCCTCC
RNA15
CTAGTTTCAGAATTCGAGCTCGTTTAAAC
F2- Myc- CTAATAGTGGCAAGGTCGGTTTGGATGACTTAAAGAAAT
PCF11
TGGTCACAAAACGGATCCCCGGGTTAATTAA
R1- Myc- TAATATAATATATAGTTATTAAATTTAAATGTATATATGC
PCF11
AGTTCTGCTCGAATTCGAGCTCGTTTAAAC
F2- Myc- GTCGCGGTGGATACAATAGACGTAATAATGGCTACCATC
HRP1
CATATAATAGGCGGATCCCCGGGTTAATTAA
R1- Myc- TGAATTATACAAGAAAACTTTTCTCTAGTTTTCTACACTT
HRP1
TTCTTTTTTTGAATTCGAGCTCGTTTAAAC
F2- Myc- GCCGACTTCCCAGCAAGGCGATGATTCTAACTTCATATA
CLP1
GATATTTAGAGCGGATCCCCGGGTTAATTAA
R2- Myc- TACGATATTTGTATGGATTTGATATAAGGCTCTTGAACA
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CLP1

GATAATTTTACGAATTCGAGCTCGTTTAAAC

F2- Myc- CTGCTTCAGGTGACAACATCAATGGCACAACCGCAGCTG
PAP1
TTGACGTAAACCGGATCCCCGGGTTAATTAA
R1- Myc- TGACTGATTAACCTATATTAATAAACTATTCAACTATAA
PAP1
ATAGGAATGTCGAATTCGAGCTCGTTTAAAC
F2-HATFIIB

TTGCTAATGGTGTAGTGTCTTTGGATAACTTACCGGGCG
TTGAAAAGAAACGGATCCCCGGGTTAATTAA

R1-HATFIIB

CACGAGTACCCGTGCTTCTTGTTCCTATAATTTACTGTTT
TATCACTTCAGAATTCGAGCTCGTTTAAAC

RNA15Myc-Diag

TCCAGGCCGCAAGAAGAG

RNA14Myc-Diag

AAGAGACTCAGAGCTTCCAACAG

PCF11Myc-Diag

GTCCAATTTGTAAGGAAACCG

HRP1Myc-Diag

AGCAAGATTCAAATGCCACTC

PAP1Myc-Diag

GTAACAGATGAAAATAAAGAGGAAGAA

CLP1Myc-Diag

TTGAGTCCTTATGCTATTGGTGTT

TFIIBHA-Diag

CCGATGCAAGTCACTACTTCTG

Myc-tagDiag
HA-tagDiag

CAAGTCTTCCTCGGAGATTAGC

5’ KIN28Myc/HAF2
3’ KIN28Myc/HAF2

TCAAAGAATTACCACCACCAAGTGACCCGTCTTCAATAAAAATACGTAA
CCGGATCCCCGGGTTAATTAA

GGTAGAGGTGTGGTCAATAAGAGC

GATACATCTAATGTCAATAACACAGATTCTACAAATTTTATAAAATCATA
GAATTCGAGCTCGTTTAAAC
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5’ KIN28Tag-Diag
5’
SSU72Myc-F2
3’
SSU72Myc-R1
5’ SSU72
–Tag
diag
5’ TFB4C-TAP

CGCCTTAGATTTTATGTGTGGA

3’ TFB4C-TAP

ATTGTGACGAAGGTTACCTGCTTGAAACGGATAATGTTCATTCCTTTCG
TTACGACTCACTATAGGG

TFB4TAPDIAG
5’ C-TAP
Ssl2

AGGACATCATGCTATTTAACAGGG

3’C-TAP
Ssl2

TATGACTGAATAGATTCAAAATAGGAAGGTGACAATGAAACCAAGCCTA
TTACGACTCACTATAGGG

5’C-TAP
SSL2Diag
5’C-TAP
kin28

TTACACATTTACACGGAATGGAG

3’C-TAP
kin28
5’C-TAP
kin28Diag
5’RNA15TAP-C

GATACATCTAATGTCAATAACACAGATTCTACAAATTTTATAAAATCATA
TACGACTCACTATAGGG
CGAAGTTTCTTCCTTTATGACG

3’RNA15
–TAP-C

ATCATTGCGGAACCGCATTTTTTTTTTGTATTTTTGCCTCCCTAGTTTCA
TACGACTCACTATAGGG

5’TAPRna15-D

TCCAGGCCGCAAGAAGAG

GGCAAAGCTCACATTCTCAACTACCGTCATTATACGCTCCTTCATATTA
CCGGATCCCCGGGTTAATTAA
ATGAGGGCCGCTTAATGCTTATGCTTTTCTACAGTAATTGACCGTTTTG
TGAATTCGAGCTCGTTTAAAC
ATGATGATGAAAATGCTAAAATTG
GGAAACCAGTTGTTCCAAGGTTGAAAGCCAAAAAGAAGGTGACGAAAC
CATCCATGGAAAAGAGAAG

AGGAACATCATCCATTAATCAGAAAGATGTATTATAAGAATTTGAAGAA
GTCCATGGAAAAGAGAAG

TCAAAGAATTACCACCACCAAGTGACCCGTCTTCAATAAAAATACGTAA
CTCCATGGAAAAGAGAAG

CTATTTGGGACTTAAAACAAAAAGCATTAAGGGGAGAATTTGGTGCATT
TTCCATGGAAAAGAGAAG
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5’Ssu72C-TAP

GGCAAAGCTCACATTCTCAACTACCGTCATTATACGCTCCTTCATATTA
CTCCATGGAAAAGAGAAG

3’Ssu72C-TAP

ATGAGGGCCGCTTAATGCTTATGCTTTTCTACAGTAATTGACCGTTTTG
TTACGACTCACTATAGGG

5’Ssu72- GTGAAGATTTGATGAATAGAGG
C-TAPDiag
3’
ANY GTTGAATTTGTTGTCTACTTTCGG
TAP Diag
C.3. ChIP Primers
INO1-ChIP
Name
CHA1 A

Sequence
GATAGCCTCTTGCGACCTTATT
CATTCATATTTCAAGAAAAATTGTG

CHA1 B

AATTCAAAAGGACGGTAAAAGAT
AAGGGATGAACATAAATGGGC

CHA1 C

GGTGGAAACGAATGGATGTC
TCTTAGTGTTGTAACCCAAATGC

CHA1 D

GGAAGAAGCGTTGGATAGCAT
CCCCTTTATACAAATTCTGTGC

MET16 ChIP
Name
INO1 A

Sequence
GCTTGTTCTGTTGTCGGGTTC
GGAGGTGATTGGAGCAATATTATC

INO1 B

GATATCCAGAATTTCAAAGAAGAAAAC
TATTCTGCGGTGAACCATTAATATAG

INO1 C

GTATTAAACCGGTCTCCATTGC
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CCGACGGGCTTCATATATTTG
INO1 D

CTCATTTCAACGACTCTCTTTTTC
GCACTTTCTCGCATCTACCTCA

HXT1 ChIP
Name
HXT1 P

Sequence
GCGATGAGATAAGATAAAAGGGA
GATTACCGATTCCTCTACTTTTGA

HXT1 M

ATTTGGTATGAAGCACCACGA
GGGCGACCTCAGATATTAGCA

HXT1 T

GGTGGAAACGAATGGATGTC
TCTTAGTGTTGTAACCCAAATGC

CHA1 ChIP
Name
CHA1 P

Sequence
GCCCCAGCGGAAATGTAA
CATTCATATTTCAAGAAAAATTGTG

CHA1 M

GCCCAGGTTATCGTGAGTG
CACCTCCACCAACGCTGC

CHA1 T

GGAAGAAGCGTTGGATAGCAT
CAGTAGTTTATGCTTTATGCTCG

CHA1 D1

GCACAGAATTTGTATAAAGGGG
GCTTTTCTTCACTTAGTAAGGATTAA

CHA1 D2

GTTCCGTAATAATCTTCCCAGC
CTGGGGTCTTCATTTGTGTCA
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ASC1 ChIP
Name
ASC1 P

Sequence
GACTGCTCCTTTGGTTTTCC
GGTTGACCAGCAGAAGTAGCC

ASC1 M

CGAAAAAGCTGATGATGACTCTG
TTGATGTTGGAGTTGTGACCG

ASC1 T

TGGCAAGTTATGACTGCTAACTAAG
GCCAAGGAGACTGAATTTAATG

ACT1 ChIP
Name
ACT1 P

Sequence
CAAACTCGCCTCTCTCTCTCC
GCAAGCGCTAGAACATACCAG

ACT1 M

CATACCTTCTACAACGAATTGAGAG
CTTCATCAAGTAGTCAGTCAAATCTC

ACT1 T

TGGTCCATCTATCGTTCACCA
ATAAAACTGAAAAGCGATGAAGAG

ACT1 D1

GTTTTGTCTCTCCCTTTTCTACG
GGTATCAAAACGCCGGACTC

ACT1 D2

CCGCCATTAGAATTTGAGTCC
TTTGCGTAACGTTTGGATGG

C.4. CCC Primers
HXT1 CCC
Name

Sequence
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HXT1 P1

TCGGGTGTTAAGAAATATTTTGC

HXT1 T1

TTAACAGATAACCGAGTCGATCTC

HXT1 C1

AATACCACATAGGCGCTATACATAG

HXT1 C2

CGTCTTTTCTTTACTGCTTCACC

CHA1 CCC
Name

Sequence

CHA1 P1

GGAAAATGTTTATACAGTTTTCTCTT

CHA1 T1

GGAAAATGTTTATACAGTTTTCTCTT

CHA1 C1

GGAAGAAGCGTTGGATAGCAT

CHA1 C2

CGTTTTGGATATGTTGATGCTTAC

ACT1 CCC
Name

Sequence

ACT1 P1

CGAGTTTGGTTTCAAAACGG

ACT1 T1

CCGCCATTAGAATTTGAGTCC

ACT1 C1

TGGTCCATCTATCGTTCACCA

ACT1 C2

AATTTTCGTAGAAAAGGGAGAGAC

ASC1 CCC
Name

Sequence

ASC1 P1

GACTGCTCCTTTGGTTTTCC

ASC1 T1

CTTTATTTCCTTTATTGTGGTATTAG

ASC1 C1

ATGCTGTTTCTTTGGCTTGG

ASC1 C2

TGTACATATGTATTTTCGCAGCA
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APPENDIX D: MEDIA
YEAST EXTRACT-PEPTON-DEXTROSE (YPD) medium (1 liter)
Component
Yeast extract
Peptone
Dextrose
Agar
NaOH

Quantity
10 g
20 g
20 g
20 g
1 pellet

INOSITOL DROP-OUT MEDIUM (1 liter)
Component
Quantity

Notes

100 ml of 20% stock-add after autoclaving
For plates only
For plates only
Notes

Ammonium Sulfate

5g

Vitamin Stock

1 ml

Of 1000X stock solution

Trace Elements Stock

1 ml

Of 1000X stock solution

Salt Mix

1.7 g

Inositol drop-out amino 230 mg
acid Mix
Dextrose
20 g

100 ml of 20% stock-add after autoclaving

TRACE ELEMNTS STOCK (1000X; 100 ml)-FOR INOSITOL DROP-OUT MEDIA
Component

Quantity

Notes

Boric acid

50 mg

Autoclave

Copper sulfate

4 mg

Store in a dark bottle at 4oC

Potassium iodide

10 mg

Ferric chloride

20 mg

Manganese sulfate

40 mg

Sodium molybdate

20 mg

Zinc sulfate

40 mg

127

VITAMIN STOCK (1000X; 100 ml)- FOR INOSITOL DROP-OUT MEDIA
Component
Quantity
Notes
Biotin

2 mg
Autoclave

Calcium pantothenate

200 mg

Folic acid

0.2 mg

Niacin

40 mg

β-Aminobenzoic acid

20 mg

Pyridoxine hydrochloride

40 mg

Riboflavin

20 mg

Thiamin hydrochloride

40 mg

SALT MIX- FOR INOSITOL DROP-OUT MEDIA
Component
Quantity
Potassium phosphate monobasic

85 g

Potassium phosphate dibasic

15 g

Magnesium sulfate

50 g

Sodium chloride

10 g

Calcium chloride

10 g

AMINO ACID MIX- FOR INOSITOL DROP-OUT MEDIA
Component
Quantity
Adenine hemisulfate

40 mg

Histidine

20 mg

Leucine

60 mg

Lysine

30 mg

Store in a dark bottle at 4oC

Notes

Notes
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Methionine

20 mg

Tryptophan

40 mg

Uracil

20 mg

INOSITOL STOCK (100 X; 100 ml)
Component
Inositol ( for plus inositol medium)

Quantity
1g

METHIONINE DROP-OUT MEDIUM (1 liter)
Component
Quantity

Notes
1 ml/ liter of inositol drop-out
medium

Notes

Yeast nitrogenous base

6.7 g

without amino acids

methionine drop-out mix

1g

agar

20 g

For plates only

NaOH

1 pellet

For plates only

Dextrose

20 g

100 ml of 20% stock-add after
autoclaving

METHIONINE DROP-OUT MIX- FOR METHIONINE DROP-OUT MEDIA
Component
Quantity
Notes
Adenine

2.5 g

L-arginine

1.2 g

L- asparatic acid

6.0 g

L- glutamic acid

6.0 g

L-Histidine

1.2 g

L-leucine

3.6 g

L-lysine

1.8 g

L-phenylalanine

3.0 g
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L-tryptophan

2.4 g

L-tyrosine

1.8 g

L-valine

9.0 g

Uracil

1.2 g

AMMONIUM SULFATE MEDIUM (1 liter)-FOR CHA1 REPRESSION
Component
Quantity
Notes
Yeast nitrogenous base

1.7 g

Ammonium sulfate

5g

Amino acid mix

230 mg

Dextrose

20 g

Without amino acids
Without ammonium sulfate

100 ml of 20% stock-add after
autoclaving

SERINE-THREONINE MEDIUM (1 liter)-FOR CHA1 ACTIVATION
Component
Quantity
Notes
Yeast nitrogenous base

1.7 g

L-serine

1g

L-threonine

1g

Amino acid mix

230 mg

Dextrose

20 g

AMINO ACID MIX FOR CHA1 MEDIA
Component
Quantity
Adenine hemisulfate

40 mg

Histidine

20 mg

Leucine

60 mg

Lysine

30 mg

Without amino acids
Without ammonium sulfate

100 ml of 20% stock-add after
autoclaving
Notes
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Methionine

20 mg

Tryptophan

40 mg

Uracil

20 mg

TRYPTON DROP-OUT MEDIUM (1 liter)
Component
Quantity
Yeast nitrogenous base

6.7 g

Trypton drop-out amino acid mix

1g

agar

20 g

NaOH

1 pellet

Dextrose

20 g

TRYPTON DROP-OUT MIX
Component

Quatity

Adenine

2.5 g

L-arginine

1.2 g

L- asparatic acid

6.0 g

L- glutamic acid

6.0 g

L-Histidine

1.2 g

L-leucine

3.6 g

L-lysine

1.8 g

L-methionine

1.2 g

L-phenylalanine

3.0 g

L-tyrosine

1.8 g

L-valine

9.0 g

Notes
without amino acids

100 ml of 20% stock-add after
autoclaving
Notes
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Uracil

1.2 g

G418 PLATES (KMX-MEDIUM) -1 liter
Component

Quantity

Notes

Yeast nitrogenous base

10.0 g

without amino acids

peptone

20.0 g

agar

20.0 g

Dextrose

20 g

G418

1.0 ml

100 ml of 20% stock-add after
autoclaving
Of 400 mg/ml

Component

Quantity

Notes

Yeast extract

10.0 g

without amino acids

Tryptone

16.0 g

NaCl

5.0 g

Agar

20.0 g

2XYT MEDIUM-1 liter

For plates only
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APPENDIX E: BUFFERS AND SOLUTIONS
STOCK SOLUTIONS
Reagent
Tris-HCl- pH 8.0

Molarity/ concentration/
percentage
1.0 M

Notes


Adjust pH using HCl

EDTA pH 7.0 to 8.0

0.5 M



Adjust pH using NaOH

NaCl

5.0 M



Autoclave

KCl

2.0M



Autoclave

SDS

10%



Filter sterilize

CaCl2

1.0 M



Autoclave

MgCl2

1.0 M



Autoclave

PEG (Mw 4000)

50 %



Filter sterilize

LiOAc

1.0 M



Filter sterilize

Glycine

2.5 M



Autoclave

Ammounium acetate

7.5 M



Autoclave

NaOAc pH 5.2

3.0 M



Glycerol

50 %



Adjust pH using glacial
acetic acid
Autoclave

Tergitol

10 %



Autoclave

Triton X-100

10 %



Filter sterilize

LiCl

5.0 M



Autoclave

HEPES pH 7.9

1.0 M



Sodium deoxycholate

10%




Adjust the pH using
KOH
Filter sterilize
Filter sterilize

KOH

10.0 M



Autoclave
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Dextrose

20 %



Autoclave

PMSF

100 mM

Glycogen

20 mg/ ml





Don’t autoclave
Keep at 4oC
Filter sterilize

DTT

1.0 M



Filter sterilize

Ethedium bromide

10.0 mg / ml

Ammonium acetate

7.5 M





Don’t autoclave
Keep at 4oC
Autoclave

TE

10X

TAE

50 X

TBS

10X








100 mM Tris.HCl pH 8.0
10 mM EDTA
2.0 M Tris-acetate
50 mM EDTA
100 mM Tris-HCl pH 8
2M NaCl

AGAROSE GEL ELECTROPHORESIS BUFFER (1X TAE)
Component
Concentration

Notes

Tris-acetate

40 mM



Autoclave

0.5 M EDTA pH 8.0

1 mM EDTA



Autoclave

SOLUTIONS FOR YEAST GENOMIC DNA EXTRACTION
Reagent
Composition
Lysis buffer

Notes

2% Triton X-100
100 mM NaCl
10 mM Tris-HCl pH 8.0
10 mM EDTA
1% SDS

SOLUTIONS FOR LiOAc/DMSO YEAST TRANSFORMATION
Reagent

Composition

LiAOAc buffer

0.1 M LiAOAc
10 mM Tris-HCl(pH=8.0)
1 mM EDTA
50 % w/v PEG (M.W. = Filter sterilize
4000)

PEG solution

Notes
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0.1 LiAOAc
10 mM Tris-HCl (pH=8.0)
1 mM EDTA
DMSO

100 %

SOLUTIONS FOR PLASMID MINIPREP
Solution

Composition

Solution I

50 mM Dex
10 mM EDTA
25 mM Tris-HCl pH 8.0
0.1 N NaOH
1% SDS
30 ml 5M KOAc
5.75 ml glacial HOAc
14.25 ml H2O

Solution II
Solution III

Notes



Store at – 20 oC

YEAST CELL WASH
component

Concentration

Notes

Wash buffer I

1X TBS



Autoclave

Wash buffer II

1XTBS
1% Triton X-100



Autoclave

CHROMATIN IMMUNOPRECIPITATION (ChIP) BUFFERS AND SOLUTIONS
FA-LYSIS BUFFER
Reagent
HEPES-KOH pH 7.9

Concentration

Notes

50 mM


NaCl

140 mM

EDTA

1 mM

Triton X-100

1%

Sodium Deoxycholate

0.1 %

PMSF

1 mM

SDS

0.07 %

Store at -20 °C

135

FA-LYSIS BUFFER + 500 mM NaCl
Reagent
Stock
Concentration
HEPES-KOH pH 7.9- 8.0
50 mM

Volume added


NaCl

500 mM

EDTA pH 8.0

1 mM

Triton X-100

1%

Sodium Deoxycholate

0.1 %

PMSF

1 mM

SDS

0.07 %

ChIP WASH BUFFER
Reagent

Store at –20 °C

Concentration Notes

Tris-HCl pH 7.5 to 8

10 mM

LiCl

250 mM

Triton X-100

0.5 %

EDTA pH 8.0

1 mM

Sodium Deoxycholate

0.5 %

SDS

0.1 %



Store at -20 °C

ChIP ELUTION BUFFER
Reagent

Concentration

Tris-HCl pH 7.5 to 8.0

50 mM

SDS

1%

EDTA pH 8.0

10 mM

Notes


Store at room temperature
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REVRESE TRANSCRIPTION PCR (RT-PCR) BUFFERS AND SOLUTIONS
HIGH TE BUFFER
Reagent
Concentration Notes
Tris-HCl pH 7.5
50 mM
 Store at RT
EDTA

20 mM

RNA-LYSIS BUFFER
Reagent

Concentration

Tris-HCl pH 8.0

80 mM

CaCl2

10 mM

β-mercatoethanol

10 mM

VCR (Shake well)

10 mM

Notes

CHROMOSOME CONFORMATION CAPTURE SOLUTION
TM BUFFER
Component
Concentration Notes
Tris HCl pH 7.5- 8.0

10 mM

MgCl 2

5 mM

TRANSCRIPTION RUN-ON ASSAY SOLUTIONS AND BUFFERS
Reagent
Composition
Notes
20X SSC

3 M NaCL
300mM Na3CitrateX2H2O

Sarkosyl

10%

Boiling solution

0.4 N NaOH
1 mM EDTA
0.5M potassium phosphate pH 7.2
7% SDS

Hybridization
solution
Membrane wash I
Membrane wash II

0.1% SDS
1% SSC
0.1% SDS
0.1% SSC



Adjust pH to 7.0
using HCl
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2.5 XRun-on buffer
NTPs/RNase
inhibitor mix

TMN buffer
NaOAc/HOAc mix

LETS buffer

50 mM Tris-HCl pH 7.5
500 mM KCl
80 mM MgCl2
5 mM DTT
10 mM each of CTP, ATP, and GTP
300 units of RNase Inhibitor
7 μl of [α-32P]-UTP (3000 Ci/mmol,
10 μCi/μl
10 mM Tris-HCl pH 7.5
5 mM MgCl2
100 mM NaCl
0.3 M sodium acetate pH 5.2
0.5 μl of glacial acetic acid
0.1 M LiCl
0.2% SDS
10 mM EDTA
10 mM Tris-HCl pH 7.5

IMMUNOPRECIPITATION ASSAY BUFFERS AND SOLUTIONS
Component
Concentration
Notes
IP lysis buffer
10% glycerol
 Autoclave
20 mM Tris-HCl pH 8.0
 Keep at 4oC
50 mM KCl
0.5 mM EDTA
1 mM MgCl2
0.1% TritonX-100
1 mM PMSF (add directly before
use)
30%Acrylamide:Bis Solution 1 % Bisacrylamide
29% Acrylamide
4% stacking gel

125 mM Tris-Cl, pH 6.8
0.1% SDS
5% Acrylamid mix
0.1 Ammonium persulfate

Electrode buffer

25 mM tris
250 mM glycine
0.1 SDS
250 mM Tris HCl pH 6.8
50 % Glycerol
10% SDS
2.8 M β-mercaptoethanol
0.1% Bromophenol blue
20% Methanol

5X laemeli buffer

Transfer Buffer



Keep at 4oC
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24 mM Tris-base
192 mM Glycine
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ABSTRACT
GENERAL TRANSCRIPTION FACTORS PLAY DUAL ROLES IN INITIATION AND
TERMINATION
by
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Gene looping, defined as the interaction of the promoter and the terminator
regions of a gene during transcription, is emerging as an important gene regulatory
mechanism in eukaryotes. The role of promoter bound general transcription factors
during initiation is well established. However, recent studies have revealed that some
initiation factors also interact with the 3’ end of a gene. The biological role of initiation
factors at the 3’ end of a gene is unknown. The general transcription factors TFIIB and
TFIIH have been found to interact genetically with Ssu72, a component of CPF 3’ end
processing complex. Accordingly, we found that TFIIB and TFIIH localize to the distal
ends of genes in a transcription dependent manner. TFIIB localization at the terminator
region during transcription requires a functional CF1 complex. TFIIB physically interacts
with the all subunits of the CF1 complex in an activator dependent manner. TFIIH also
interacts with the CF1 and CPF 3’ end processing complexes in a manner depending on
its kinase activity. Employing

affinity

chromatography

and

glycerol gradient

centrifugation, we show that TFIIB associates with poly(A) polymerase and the

CF1

complex in yeast cells to form a holo-TFIIB complex. This complex was resistant to
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MNase digestion and brief exposure to high salt. The sedimentation coefficient of the
holo-TFIIB complex was intermediate between that of TFIIH and TFIID. Initiation factors
which remain bound on a promoter scaffold in vitro, were not found in a holo-TFIIB
complex with termination factors. The holo-TFIIB complex was observed only in the
looping competent strains, but not in the looping defective sua7-1 strain. We further
show that in sua7-1 cells, where a holo-TFIIB complex is not formed, the kinetics of
activated transcription is altered. These results strongly suggest a role for TFIIB in
termination of transcription. Similarly, the kinase dependent presence of TFIIH at the 3’
end of genes suggested a role for the factor in termination. Accordingly, we show that
RNAP II read through the termination signal in the absence of Kin28 kinase activity.
Furthermore, the recruitment of CF1 and CPF subunits at the 3’ end of a gene is
impaired in the TFIIH kinase defective mutant. We propose that initiation factors are in
contact with the terminator during gene looping and play an active role in transcription
termination.
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